1 00:00:08,868 --> 00:00:11,070 WELCOME TO THE CLINICAL CENTER GRAND ROUNDS, 2 00:00:11,070 --> 00:00:14,874 A WEEKLY SERIES OF EDUCATIONAL LECTURES FOR PHYSICIANS AND 3 00:00:14,874 --> 00:00:17,510 HEALTH CARE PROFESSIONALS BROADCAST FROM THE CLINICAL 4 00:00:17,510 --> 00:00:20,480 CENTER AT THE NATIONAL INSTITUTES OF HEALTH IN 5 00:00:20,480 --> 00:00:22,282 BETHESDA, MD. 6 00:00:22,282 --> 00:00:25,819 THE NIH CLINICAL CENTER IS THE WORLD'S LARGEST HOSPITAL TOTALLY 7 00:00:25,819 --> 00:00:29,522 DEDICATED TO INVESTIGATIONAL RESEARCH AND LEADS THE GLOBAL 8 00:00:29,522 --> 00:00:32,459 EFFORT IN TRAINING TODAY'S INVESTIGATORS AND DISCOVERING 9 00:00:32,459 --> 00:00:34,627 TOMORROW'S CURES. 10 00:00:34,627 --> 00:00:44,510 LEARN MORE BY VISITING US ONLINE AT HTTP://CLINICALCENTER.NIH.GOV 11 00:00:44,510 --> 00:00:46,178 THANK YOU ALL FOR JOINING US 12 00:00:46,178 --> 00:00:47,446 TODAY ONLINE AND IN PERSON. 13 00:00:47,446 --> 00:00:49,081 VERY NICE TO SEE EVERYONE HERE. 14 00:00:49,081 --> 00:00:50,482 IT'S MY GREAT PLEASURE TO 15 00:00:50,482 --> 00:00:53,585 WELCOME YOU TO TODAY'S CLIPICAL 16 00:00:53,585 --> 00:00:55,854 CENTER GRAND ROUNDS. 17 00:00:55,854 --> 00:00:57,923 THE HOPKINS CLOUD CME ARCKIVITY 18 00:00:57,923 --> 00:01:01,727 CODE FOR TODAY'S GRAND ROUNDS 19 00:01:01,727 --> 00:01:02,160 AND 50529. 20 00:01:02,160 --> 00:01:04,696 AND TEXT THIS CODE TO JOHNS 21 00:01:04,696 --> 00:01:07,766 HOPKINS CME PHONE NUMBER ON THE 22 00:01:07,766 --> 00:01:09,768 SLIDE AND THEN YOU CAN RECEIVE 23 00:01:09,768 --> 00:01:11,637 YOUR CME CREDIT IF ARE THIS 24 00:01:11,637 --> 00:01:12,104 LECTURE. 25 00:01:12,104 --> 00:01:13,405 WE KINDLY INVITE TO YOU PRORIDE 26 00:01:13,405 --> 00:01:15,140 ANY FEEDBACK ON TODAY'S LECTURE 27 00:01:15,140 --> 00:01:18,477 BY SCANNING THE QR CODE ON THE 28 00:01:18,477 --> 00:01:20,612 CME SLIDE AND FOR THOSE APPLYING 29 00:01:20,612 --> 00:01:22,681 FOR CME, YOU WILL RECEIVE A 30 00:01:22,681 --> 00:01:25,784 FEEDBACK SURVEY VIA E-MAIL LINK. 31 00:01:25,784 --> 00:01:28,554 THE SURVEY WILL BE USED TO 32 00:01:28,554 --> 00:01:30,155 PROVIDE US WITH IMPORTANT 33 00:01:30,155 --> 00:01:31,557 FEEDBACK ABOUT THIS PRESENTATION 34 00:01:31,557 --> 00:01:34,226 AND ALLOWS TO YOU SUBMIT ANY 35 00:01:34,226 --> 00:01:36,228 SUGGESTIONS FOR FUTURE GRANDS 36 00:01:36,228 --> 00:01:39,431 ROUNDS TOPICS, FOLLOWING THE 37 00:01:39,431 --> 00:01:40,365 PRESENTATION QUESTIONS FOR THE 38 00:01:40,365 --> 00:01:42,034 SPEAKER WILL BE TAKEN FROM 39 00:01:42,034 --> 00:01:44,436 MICROPHONES IN THE AISLES, AS 40 00:01:44,436 --> 00:01:46,772 WELL AS VIDEOCAST VIEWERS MAY 41 00:01:46,772 --> 00:01:48,840 SUBMIT A QUESTIONS AT ANY TIME 42 00:01:48,840 --> 00:01:50,609 BY SCROLLING DOWN AND CLICKING 43 00:01:50,609 --> 00:01:52,578 THE LIVE FEEDBACK BUTTON LOCATED 44 00:01:52,578 --> 00:01:54,279 ON THE VIEDMANIOY CAST WEBSITE. 45 00:01:54,279 --> 00:01:55,781 QUESTIONS WILL BE ANSWERED AS 46 00:01:55,781 --> 00:01:57,249 TIME PERMITSA THE CONCLUSION OF 47 00:01:57,249 --> 00:01:57,883 THE PRESENTATION. 48 00:01:57,883 --> 00:02:00,752 SO I'M VERY PLEASED AS THE 49 00:02:00,752 --> 00:02:02,521 CLINICAL DIRECTOR OF NIMH TO 50 00:02:02,521 --> 00:02:04,456 INTRODUCE TODAY'S SPEAKER, 51 00:02:04,456 --> 00:02:05,257 DR. PETER SCHMIDT. 52 00:02:05,257 --> 00:02:11,096 HE'S THE CHIEF OF THE 53 00:02:11,096 --> 00:02:13,799 BEHAVIORIAL ENDOCRINE BRANCH OF 54 00:02:13,799 --> 00:02:15,000 THE NATIONAL INNSITUTE OF MENTAL 55 00:02:15,000 --> 00:02:19,972 HEALTH AND HE'S THE DIRECTOR OF 56 00:02:19,972 --> 00:02:21,707 THE CLINIC ON OP4. 57 00:02:21,707 --> 00:02:23,041 HE EARNED HADIS BACHELORS FROM 58 00:02:23,041 --> 00:02:25,010 THE UNIVERSITY OF TORONTO, HE 59 00:02:25,010 --> 00:02:27,212 THEN EARNED A BACHELOR'S OF 60 00:02:27,212 --> 00:02:28,814 MEDICINE AND SURGERY WITH HONORS 61 00:02:28,814 --> 00:02:31,116 WITH THE ROYAL COLLEGE OF 62 00:02:31,116 --> 00:02:35,020 SURGEONS IN IRELAND, AND HE 63 00:02:35,020 --> 00:02:36,855 RETURNED TO THE UNIVERSITY OF 64 00:02:36,855 --> 00:02:39,925 TORONTO WHERE HE COMPLETED HIS 65 00:02:39,925 --> 00:02:40,859 RESIDENCY IN PSYCHEISTRY AND 66 00:02:40,859 --> 00:02:43,195 CAME TO THE NIMH IN 1986, FIRST 67 00:02:43,195 --> 00:02:45,631 TO THE UNIT IN PEPTIDE STUDIES 68 00:02:45,631 --> 00:02:48,000 IN THE BIOLOGICAL PSYCHIATRY 69 00:02:48,000 --> 00:02:50,068 BRANCH AND JOINED WHAT IS NOW 70 00:02:50,068 --> 00:02:52,270 KNOWN AS THE BEHAVIORIAL 71 00:02:52,270 --> 00:02:53,905 ENDOCRINE BRANCH THAT HE NOW 72 00:02:53,905 --> 00:02:54,139 LEADS. 73 00:02:54,139 --> 00:02:57,075 MANY MAY NOT KNOW THAT 74 00:02:57,075 --> 00:02:58,110 DR. SCHMIDT ALSO SERVED AS 75 00:02:58,110 --> 00:03:00,312 DREBTOR AND SOCIAL DIRECTOR OF 76 00:03:00,312 --> 00:03:06,551 THE PSYCHIATRY LIAISON SERVICE 77 00:03:06,551 --> 00:03:09,888 BEFORE I ARRIVED AND HE'S BEEN A 78 00:03:09,888 --> 00:03:12,190 TRUSTED CLINICAL ADVISOR ON THE 79 00:03:12,190 --> 00:03:15,727 OP4 ACTIVITIES AND THE IRP. 80 00:03:15,727 --> 00:03:18,196 DR. SCHMIDT SERVES AS AN 81 00:03:18,196 --> 00:03:21,133 ASSOCIATE PROFESSOR IN THE MOOD 82 00:03:21,133 --> 00:03:22,534 PROGRAM AT THE UNIVERSITY OF THE 83 00:03:22,534 --> 00:03:25,203 MARYLAND A POSITION SINCE 2000 84 00:03:25,203 --> 00:03:26,505 AND ADJUNCT PROFESSOR OF THE 85 00:03:26,505 --> 00:03:28,006 DEPARTMENT OF PSYCHIATRY AT THE 86 00:03:28,006 --> 00:03:29,074 UNIVERSITY OF NORTH CAROLINA 87 00:03:29,074 --> 00:03:29,908 CHAPEL HILL. 88 00:03:29,908 --> 00:03:32,878 A POSITION HE'S HELD SINCE 2007. 89 00:03:32,878 --> 00:03:36,014 HE HAS OF COURSE SERVED ON 90 00:03:36,014 --> 00:03:37,549 NUMEROUS NIH COMMITTEES WRITTEN 91 00:03:37,549 --> 00:03:40,052 200 PAPERS INCLUDING IN THE NEW 92 00:03:40,052 --> 00:03:43,155 ENGLAND JOURNAL MANY IN THEIR 93 00:03:43,155 --> 00:03:47,159 JAMA, JOURNAL OF PSYCHIATRY AND 94 00:03:47,159 --> 00:03:48,427 MOLECULAR PSYCHIATRY, IF I SPEND 95 00:03:48,427 --> 00:03:50,062 ALL MY TIME TELLING BUT HIS 96 00:03:50,062 --> 00:03:51,830 PAPER AND AWARDS HE WOULDN'T GET 97 00:03:51,830 --> 00:03:55,867 TO HIS LECTURE EMPLOY HE'S 98 00:03:55,867 --> 00:03:58,704 SERVED ON THE PREMEN TRAL 99 00:03:58,704 --> 00:04:02,240 DYSPHORIC GROUP, CHAIRED ON THE 100 00:04:02,240 --> 00:04:05,277 SOCIETY OF NEUROPHARMA COALING 101 00:04:05,277 --> 00:04:07,679 AND AT NIMH THE WORK THAT 102 00:04:07,679 --> 00:04:09,614 DR. SCHMIDT AND HIS COLLEAGUES 103 00:04:09,614 --> 00:04:11,583 HAVE WORKED ON HAS LED TO THE 104 00:04:11,583 --> 00:04:12,517 IMPORTANT ENDOCRINE MODELS THAT 105 00:04:12,517 --> 00:04:15,954 CLARIFY THE ROLE OF REPRODUCTIVE 106 00:04:15,954 --> 00:04:18,056 HORMONES OF MOOD DEVELOPMENT 107 00:04:18,056 --> 00:04:19,224 DISORDERS IN WOMEN. 108 00:04:19,224 --> 00:04:21,193 HIS LABORATORY STUDIES, THE 109 00:04:21,193 --> 00:04:22,327 RELATIONSHIP BETWEEN HORMONE 110 00:04:22,327 --> 00:04:23,495 STRESS AND MOOD PARTICULARLY IN 111 00:04:23,495 --> 00:04:28,934 THE AREAS OF POSTPARTUM, 112 00:04:28,934 --> 00:04:30,969 DEPRESSION, SEVERE PREMENSTRUAL 113 00:04:30,969 --> 00:04:31,970 DYSPHORIA AND PERIPAUSAL 114 00:04:31,970 --> 00:04:36,007 DEPRESSION, HIS LAB BEGAN 115 00:04:36,007 --> 00:04:37,409 INITIATIVE TO LONGITUDINALLY TO 116 00:04:37,409 --> 00:04:40,045 THE DEVELOPMENT EFFECTS OF SEX 117 00:04:40,045 --> 00:04:41,313 STEROIDS DURING PUBERTY, I 118 00:04:41,313 --> 00:04:42,514 APPRECIATE HIS RIGOR AND 119 00:04:42,514 --> 00:04:44,616 MENTORING, TODAY HE WILL PRESENT 120 00:04:44,616 --> 00:04:50,088 HIS LECTURE ENTITLED DEPRESSION 121 00:04:50,088 --> 00:04:51,790 DURING PERIMENOPAUSE, ENDOCRINE 122 00:04:51,790 --> 00:04:52,157 CHARACTERISTICS. 123 00:04:52,157 --> 00:04:56,762 PLEASE JOIN ME IN WELCOMING 124 00:04:56,762 --> 00:04:57,062 DR. SCHMIDT. 125 00:04:57,062 --> 00:04:57,429 [ APPLAUSE ] 126 00:04:57,429 --> 00:05:01,066 >> THANK YOU MARILYN FOR THOSE 127 00:05:01,066 --> 00:05:03,835 GENEROUS COMMENTS AND I'M DPLAD 128 00:05:03,835 --> 00:05:07,606 OUR CONVERSATIONS HAVE BEEN 129 00:05:07,606 --> 00:05:08,140 MUTUALLY USEFUL. 130 00:05:08,140 --> 00:05:10,342 JUST TO GET STARTED I HAVE 131 00:05:10,342 --> 00:05:11,009 NOTHING TO DISCLOSE. 132 00:05:11,009 --> 00:05:14,546 I WILL BE MENTIONING IN PASSING, 133 00:05:14,546 --> 00:05:17,783 THE USE OF EXPERIMENTAL USE OF 134 00:05:17,783 --> 00:05:18,617 AN ESTROGEN RECEPTOR BETA 135 00:05:18,617 --> 00:05:21,820 AGONIST IN THE TREATMENT OF 136 00:05:21,820 --> 00:05:26,124 POTENTIAL TREATMENT OF 137 00:05:26,124 --> 00:05:26,658 PERIMENOPAUSAL DEPRESSION. 138 00:05:26,658 --> 00:05:27,559 LEARNING OBJECTIVES WILL BE 139 00:05:27,559 --> 00:05:28,827 FOCUSING ON THE RELATIONSHIP, OR 140 00:05:28,827 --> 00:05:30,095 STUDIES ON THE RELATIONSHIP 141 00:05:30,095 --> 00:05:33,865 BETWEEN DEPRESSION AND THE 142 00:05:33,865 --> 00:05:34,199 PERIMENOPAUSE. 143 00:05:34,199 --> 00:05:36,401 SO MUCH OF OUR WORK IN THE 144 00:05:36,401 --> 00:05:38,403 CLINIC AS FOCUSED ON 145 00:05:38,403 --> 00:05:40,038 REPRODUCTIVE MOOD DISORDERS BUT 146 00:05:40,038 --> 00:05:42,674 AS MARILYN MENTIONED, WE'VE ALSO 147 00:05:42,674 --> 00:05:44,843 STARTED AN INITIATIVE IN 148 00:05:44,843 --> 00:05:45,877 COLLABORATION WITH KAREN BERM AN 149 00:05:45,877 --> 00:05:48,647 AND JACK AND LINNET, AND TRYING 150 00:05:48,647 --> 00:05:53,552 TO UNDERSTAND THE IMPACT OF THE 151 00:05:53,552 --> 00:05:54,920 PHYSIOLOGIC EVENTS RELATED TO 152 00:05:54,920 --> 00:05:56,321 PUBERTY ON NORMAL BRAIN 153 00:05:56,321 --> 00:05:57,522 DEVELOPMENT OR TYPICAL BRAIN 154 00:05:57,522 --> 00:05:57,823 DEVELOPMENT. 155 00:05:57,823 --> 00:06:01,259 MOST OF MY WORK OVER THE LAST 156 00:06:01,259 --> 00:06:03,895 DECK'SS HAVE FOCUSED ON 2 157 00:06:03,895 --> 00:06:07,365 QUESTIONS, FIRST, IS ARE THESE 158 00:06:07,365 --> 00:06:07,933 REPRODUCTIVE MOOD DISORDERS 159 00:06:07,933 --> 00:06:11,169 LINKED TO THE PERIODS OF 160 00:06:11,169 --> 00:06:11,903 REPRODUCTIVE ENDOCRINOLOGY IN 161 00:06:11,903 --> 00:06:13,972 WHICH THEY ARE REPORTED TO 162 00:06:13,972 --> 00:06:14,172 OCCUR. 163 00:06:14,172 --> 00:06:16,074 AND SECOND, IF THAT'S THE CASE, 164 00:06:16,074 --> 00:06:19,344 THEN WHAT WOULD BE THE MECHANISM 165 00:06:19,344 --> 00:06:21,513 WHEREBY A CHANGE, OTHERWISE AH 166 00:06:21,513 --> 00:06:24,282 TENSIBLY NORMAL CHANGE THIS 167 00:06:24,282 --> 00:06:25,717 PHYSIOLOGY WOULD TRANSLATE INTO 168 00:06:25,717 --> 00:06:28,153 AN ALTERATION IN MOOD STATE IN 169 00:06:28,153 --> 00:06:28,653 THESE WOMEN. 170 00:06:28,653 --> 00:06:33,158 SO THESE ARE THE CONDITIONS THAT 171 00:06:33,158 --> 00:06:36,695 WE STUDY. 172 00:06:36,695 --> 00:06:39,431 PERPERIMEN PAUSAL DEPRESSION, 173 00:06:39,431 --> 00:06:40,131 PERIMENSTRUAL DISORDER, 174 00:06:40,131 --> 00:06:40,966 POSTPARTUM DEPRESSION, KAREN AND 175 00:06:40,966 --> 00:06:45,770 I ARE STARTING A NEW INITIATIVE 176 00:06:45,770 --> 00:06:47,272 ON POSTPARTUM PSYCHOSIS. 177 00:06:47,272 --> 00:06:48,874 SO THESE CONDITIONS ARE 178 00:06:48,874 --> 00:06:50,575 PREVALENT, THEY'RE ASSOCIATE 179 00:06:50,575 --> 00:06:51,810 WIDE CONSIDERABLE DISABILITY, 180 00:06:51,810 --> 00:06:53,979 THEY OCCUR IN WOMEN AT DIFFERENT 181 00:06:53,979 --> 00:06:56,047 PHASES OF THEIR LIFE CYCLE. 182 00:06:56,047 --> 00:06:59,217 BUT THEY'RE NOT FROM WHAT WE 183 00:06:59,217 --> 00:07:00,919 UNDERSTAND THE SAME CONDITION 184 00:07:00,919 --> 00:07:04,356 AND IN CONTRAST TO TYPICAL 185 00:07:04,356 --> 00:07:08,727 ENDOCRINE OPEN MEETINGATHY SAY 186 00:07:08,727 --> 00:07:10,795 HYPO OR HYPER THYROIDISM WHERE 187 00:07:10,795 --> 00:07:12,631 BRAIN SYMPTOMS CAN OCCUR IN SOME 188 00:07:12,631 --> 00:07:16,301 PEOPLE WHO HAVE TOO HIGH OR TOO 189 00:07:16,301 --> 00:07:17,168 LOW THYROID HORMONE. 190 00:07:17,168 --> 00:07:18,937 THERE'S NO EVIDENCE OF 191 00:07:18,937 --> 00:07:19,871 DEFICIENCY OF EXCESSIVE HORMONE 192 00:07:19,871 --> 00:07:21,539 IN ANY OF THESE CONDITIONS AND 193 00:07:21,539 --> 00:07:24,542 THERE'S BEEN MULTIPLE STUDIES TO 194 00:07:24,542 --> 00:07:26,177 KIND OF CONFIRM THAT, SO THESE 195 00:07:26,177 --> 00:07:28,413 ARE NOT TYPICAL ENDOCRINE 196 00:07:28,413 --> 00:07:29,080 OPERATING GLOBALLYATHYS PER SE, 197 00:07:29,080 --> 00:07:32,484 WHAT WE HAVE NOTICED IS ACROSS 198 00:07:32,484 --> 00:07:36,288 ALL THESE CONDITIONS IS A TERM 199 00:07:36,288 --> 00:07:36,988 CALLED THE DIFFERENTIAL 200 00:07:36,988 --> 00:07:40,525 SENSITIVITY WHICH IS NOT 201 00:07:40,525 --> 00:07:41,860 UNFAMILIAR IN ENDOCRINOLOGY OR 202 00:07:41,860 --> 00:07:43,828 ANY OTHER BRARCH BRAP OF 203 00:07:43,828 --> 00:07:45,430 MEDICINE WHERE THE SAME CHANGE 204 00:07:45,430 --> 00:07:48,300 IN A HORMONE ELICIT A CHANGE IN 205 00:07:48,300 --> 00:07:51,836 WOMEN THAT ARE AT RISK THAT'S 206 00:07:51,836 --> 00:07:53,705 UNSEEN AND IN UNAFFECTED WOMEN. 207 00:07:53,705 --> 00:07:55,140 HOWEVER THE HORMONE AT CHANGE 208 00:07:55,140 --> 00:07:56,207 DIFFERS ACROSS THE CONDITIONS 209 00:07:56,207 --> 00:07:57,943 WHERE MAYBE THE EXPOSURE TO 210 00:07:57,943 --> 00:08:00,045 HORMONES THAT TRIGGER TRIGGER 211 00:08:00,045 --> 00:08:01,780 SYMPTOMS AND PREMENSE STRAL 212 00:08:01,780 --> 00:08:02,614 DYSPHORIC DISORDER WHERE IT 213 00:08:02,614 --> 00:08:04,783 SEEMS TO BE THE WITHDRAWAL OF 214 00:08:04,783 --> 00:08:06,384 HORMONES IN SYMPTOMS AND 215 00:08:06,384 --> 00:08:07,018 POSTPARTUM DEPRESSION OR AS I 216 00:08:07,018 --> 00:08:09,955 WILL SHOW YOU LATER IN MY TALK, 217 00:08:09,955 --> 00:08:10,488 PERIMENOPAUSAL DEPRESSION. 218 00:08:10,488 --> 00:08:12,791 SO WHAT I WILL DO TODAY IS 219 00:08:12,791 --> 00:08:14,359 FOCUSING ON REALLY, OUR TODAYS 220 00:08:14,359 --> 00:08:15,327 ON THE RELATIONSHIP BETWEEN 221 00:08:15,327 --> 00:08:17,529 DEPRESSION AND THE MENOPAUSE 222 00:08:17,529 --> 00:08:20,065 TRANSITION OR THE PERIMENOPAUSE. 223 00:08:20,065 --> 00:08:22,934 I'LL TALK ABOUT OUR WORK IN THE 224 00:08:22,934 --> 00:08:24,836 LONGITUDINAL STUDY FOLLOWING 225 00:08:24,836 --> 00:08:26,771 PERSPECTIVELY, WOMEN AS THEY GO 226 00:08:26,771 --> 00:08:27,939 THROUGH THE MENOPAUSE 227 00:08:27,939 --> 00:08:29,074 TRANSITION, STUDIES ELECTRICKING 228 00:08:29,074 --> 00:08:32,143 AT THE EFFECTS OF 229 00:08:32,143 --> 00:08:32,844 ESTRADISCIPLINARYOLE WITHDRAWAL 230 00:08:32,844 --> 00:08:33,979 IN MOOD SYMPTOMS IN THESE 231 00:08:33,979 --> 00:08:35,647 MENTION AND A BREF MENTION OF AN 232 00:08:35,647 --> 00:08:36,381 ONGOING TRIAL WHERE WE'RE 233 00:08:36,381 --> 00:08:38,583 LOOKING AT THE EFFECTS OF AN E. 234 00:08:38,583 --> 00:08:40,418 R. BETA AGONIST IN THIS 235 00:08:40,418 --> 00:08:41,586 CONDITION AND THEN I WILL END 236 00:08:41,586 --> 00:08:45,156 THIS WORK THAT WE DO IN 237 00:08:45,156 --> 00:08:46,925 COLLABORATION WITH DAVID 238 00:08:46,925 --> 00:08:47,859 GOLDMAN'S LABORATORY WHERE WE 239 00:08:47,859 --> 00:08:51,196 TRY TO DEVELOP INVITRO MODELS TO 240 00:08:51,196 --> 00:08:51,863 RECAPITULATE THE HORMONAL 241 00:08:51,863 --> 00:08:52,864 EXPERIMENTS WE DO IN THE CLINIC 242 00:08:52,864 --> 00:08:57,736 AND TRY TO UNDERSTAND SOME OF 243 00:08:57,736 --> 00:08:59,671 THE CELLULAR, UNDERLYING 244 00:08:59,671 --> 00:09:01,406 CELLULAR BIOLOGY AND SIGNALING 245 00:09:01,406 --> 00:09:02,707 THAT MAY BE PRESENT IN THESE 246 00:09:02,707 --> 00:09:02,907 WOMEN. 247 00:09:02,907 --> 00:09:09,814 SO JUST TO START WITH, BACK IN 248 00:09:09,814 --> 00:09:12,784 2000, PRIOR TO THAT THERE IS NOT 249 00:09:12,784 --> 00:09:14,085 MUCH OF AN AGREEMENT OR 250 00:09:14,085 --> 00:09:16,287 CONSENSUS ON WHETHER THERE'S ANY 251 00:09:16,287 --> 00:09:18,423 ASSOCIATION BETWEEN DEPRESSION 252 00:09:18,423 --> 00:09:18,857 AND MENOPAUSE. 253 00:09:18,857 --> 00:09:21,659 AND THAT WAS LARGELY RELATED TO 254 00:09:21,659 --> 00:09:25,430 WORK DONE IN A CONDITION CALLED 255 00:09:25,430 --> 00:09:27,766 INVOLUNTEERSUTIONAL MEL AN 256 00:09:27,766 --> 00:09:29,167 ALCOHOLLIA, BUT SEVERAL STUDIES 257 00:09:29,167 --> 00:09:31,603 THAT WERE COMMUNITY BASED, LARGE 258 00:09:31,603 --> 00:09:32,303 SCALE, PROSPECTIVELY FOLLOWING 259 00:09:32,303 --> 00:09:35,473 WOMEN AS THEY WENT THROUGH THEIR 260 00:09:35,473 --> 00:09:37,308 REPRODUCTIVE STATES THROUGH 261 00:09:37,308 --> 00:09:39,344 THEIR LAST MENSTRUAL PERIOD, 262 00:09:39,344 --> 00:09:40,211 IDENTIFIED THAT FOR SOME WOMEN, 263 00:09:40,211 --> 00:09:42,347 THIS WAS A PERIOD OF INCREASED 264 00:09:42,347 --> 00:09:42,947 RISK FOR DEPRESSION. 265 00:09:42,947 --> 00:09:45,784 IN FACT, THERE WAS A 2-3 FOLD 266 00:09:45,784 --> 00:09:47,952 INCREASED RISK OF BOTH FIRST 267 00:09:47,952 --> 00:09:49,287 ONSET, SO IT'S NOT JUST WOMEN 268 00:09:49,287 --> 00:09:51,456 WHO HAD A PREVIOUS DEPRESSION, 269 00:09:51,456 --> 00:09:54,492 BUT ALSO RECURRENT DEPRESSIONS. 270 00:09:54,492 --> 00:09:57,162 SO THAT SUDDENLY 271 00:09:57,162 --> 00:09:58,063 SHOWED--DEMONSTRATED A SIGNAL 272 00:09:58,063 --> 00:10:00,031 THAT WAS PRESENT BUT IT WAS NOT 273 00:10:00,031 --> 00:10:01,933 IN THE POST MENOPAUSE, IT WAS IN 274 00:10:01,933 --> 00:10:03,334 THE TRANSITION FROM REPRODUCTIVE 275 00:10:03,334 --> 00:10:06,237 LIFE TO THE MENOPAUSE. 276 00:10:06,237 --> 00:10:09,074 THE ESTIMATES ARE THAT THIS MAY 277 00:10:09,074 --> 00:10:11,476 OCCUR IN 20-30%. 278 00:10:11,476 --> 00:10:14,012 SO WHAT'S CLEAR IS THAT THE MAR 279 00:10:14,012 --> 00:10:17,182 JORRITY OF WOMEN GO THROUGH THE 280 00:10:17,182 --> 00:10:18,116 MENOPAUSE TANSITION WITHOUT 281 00:10:18,116 --> 00:10:19,717 DEVELOPING ANY KIND BE OF 282 00:10:19,717 --> 00:10:21,719 AFFECTIVE OR MOOD DISTURBANCE. 283 00:10:21,719 --> 00:10:23,354 FOR SOME IT CAN BE VERY 284 00:10:23,354 --> 00:10:23,621 IMPORTANT. 285 00:10:23,621 --> 00:10:25,123 ADDITIONALLY FROM THE WOMEN'S 286 00:10:25,123 --> 00:10:26,324 HELT INITTIAIVE IT AND OTHER 287 00:10:26,324 --> 00:10:28,026 STUDIES SHOWED THAT EVEN THE 288 00:10:28,026 --> 00:10:30,195 PRESENCE OF MINOR DEPRESSION IN 289 00:10:30,195 --> 00:10:31,863 A PERIOR POST MENOPAUSAL WOMEN 290 00:10:31,863 --> 00:10:34,466 THAT OVER A 5 YEAR FOLLOW UP 291 00:10:34,466 --> 00:10:36,134 PERIOD CONTROLLING FOR OTHER 292 00:10:36,134 --> 00:10:39,003 RISK FACTORED SHOWED A 50% 293 00:10:39,003 --> 00:10:39,838 INCRACY IN CARDIOVASCULAR 294 00:10:39,838 --> 00:10:40,972 MORTALITY SO THIS IS SOMETHING 295 00:10:40,972 --> 00:10:43,842 THAT IS IN THE SICKIATRIC 296 00:10:43,842 --> 00:10:45,510 LITERATURE WHERE THERE'S A 297 00:10:45,510 --> 00:10:47,112 CLUSTERING OF DEPRESSION, 298 00:10:47,112 --> 00:10:49,380 METABOLEC DYSFUNCTION AND HEART 299 00:10:49,380 --> 00:10:51,082 DISEASE AND GIVEN THAT THIS IS 300 00:10:51,082 --> 00:10:53,051 THE HEART DISEASE IS THE NUMBER 301 00:10:53,051 --> 00:10:55,820 1 CAUSE OF MORTALITY IN WOMEN AT 302 00:10:55,820 --> 00:10:58,623 THIS AGE, THAL SEEMED TO BE A 303 00:10:58,623 --> 00:11:00,658 PRETTY IMPORTANT POTENTIAL 304 00:11:00,658 --> 00:11:03,528 MEDICAL SEQUELA OF DEPRESSION 305 00:11:03,528 --> 00:11:04,929 DURING THE PERIMENOPAUSE AS WELL 306 00:11:04,929 --> 00:11:06,764 AS EMOTIONAL DISABILITY THAT 307 00:11:06,764 --> 00:11:07,398 ACCOMPANYS IT. 308 00:11:07,398 --> 00:11:10,668 SO WHAT HAPPENS DURING THE 309 00:11:10,668 --> 00:11:10,969 MENOPAUSE? 310 00:11:10,969 --> 00:11:12,570 AS YOU KNOW WOMEN WITH OVARIES 311 00:11:12,570 --> 00:11:18,243 ARE BORN WITH ABOUT 400, 500,000 312 00:11:18,243 --> 00:11:20,678 PRIMORDIAL FOLLICLES IN THEIR 313 00:11:20,678 --> 00:11:21,880 OVARIES AND THERE'S AN ATTRITION 314 00:11:21,880 --> 00:11:27,685 OF THESE OVER THE COURSE OF YOU 315 00:11:27,685 --> 00:11:30,088 KNOW EACH OFUE LATTERY CYCLE AND 316 00:11:30,088 --> 00:11:30,588 WITH AGE. 317 00:11:30,588 --> 00:11:34,125 HOWEVER, THERE IS A RAPID 318 00:11:34,125 --> 00:11:35,627 DECLINE AT AROUND AGE 40, 319 00:11:35,627 --> 00:11:37,996 MIDLIFE IN WOMEN THAT IS RELATED 320 00:11:37,996 --> 00:11:41,933 AND ULTIMATELY ENDS IN THE 321 00:11:41,933 --> 00:11:42,200 MENOPAUSE. 322 00:11:42,200 --> 00:11:45,603 NOW THIS IS A SLAYED I BORROWED 323 00:11:45,603 --> 00:11:48,573 IN JAN HALL WHO'S DOWN IN NORTH 324 00:11:48,573 --> 00:11:49,874 CAROLINA MANY YEARS AGO SO THIS 325 00:11:49,874 --> 00:11:52,644 IS A KEEMATTIC OF THE 3, OF THE 326 00:11:52,644 --> 00:11:58,950 LEVELS OF CONTROL OF 327 00:11:58,950 --> 00:12:04,956 REPRODUCTIVE AXIS AND GNRH IS 328 00:12:04,956 --> 00:12:07,725 STIMUTING THE PITUITARYY FOR LH 329 00:12:07,725 --> 00:12:09,827 AND FSH, WHICH STIMULATE THE 330 00:12:09,827 --> 00:12:10,195 OVARY. 331 00:12:10,195 --> 00:12:12,096 THE OVARY PRODUCES A NUMBER OF 332 00:12:12,096 --> 00:12:13,164 HORMONES INCLUING 2 TERROIDS 333 00:12:13,164 --> 00:12:17,035 THAT WILL BE FOCUSING ON, 334 00:12:17,035 --> 00:12:17,535 ESTRADISCIPLINARYOLE AND 335 00:12:17,535 --> 00:12:18,670 PROJECTOR OWN AS WELL AS SOME 336 00:12:18,670 --> 00:12:22,106 KIND OF SMALL PROTEIN MOLECULES, 337 00:12:22,106 --> 00:12:25,743 THE INHIB THORSINS AND THE 338 00:12:25,743 --> 00:12:28,046 FOLLICLE STATINS, AND THE INHIB 339 00:12:28,046 --> 00:12:28,513 THORSINS, FEEDBACK AND 340 00:12:28,513 --> 00:12:30,448 ININCREASE IN BODY HIT AT THE 341 00:12:30,448 --> 00:12:32,550 LEVEL OF THE PITUE TARY. 342 00:12:32,550 --> 00:12:36,621 AND AS WHAT HAPPENED IN THE 343 00:12:36,621 --> 00:12:38,923 MENOPAUSE AS ESTROGEN AND 344 00:12:38,923 --> 00:12:40,325 PROGESTERONE LEVELS FALL, INHIB 345 00:12:40,325 --> 00:12:43,895 THORSIN LEVELS DECREASE AND THAT 346 00:12:43,895 --> 00:12:47,599 REMOVES LH AND FSH WHICH ARE 347 00:12:47,599 --> 00:12:48,199 EVENTUALLY TONICALLY ELEVATED. 348 00:12:48,199 --> 00:12:50,034 SO THOSE ARE SOME OF THE MARKERS 349 00:12:50,034 --> 00:12:52,937 OF THE PERO MENOPAUSE WE HAVE 350 00:12:52,937 --> 00:12:53,271 INCLUED. 351 00:12:53,271 --> 00:12:56,507 THIS IS AN OLD SCHEMATIC JUST 352 00:12:56,507 --> 00:12:59,377 SHOWING THE DIFFERENCES IN THE 353 00:12:59,377 --> 00:13:00,245 ESTRA-DIAL AND PROGESTERONE 354 00:13:00,245 --> 00:13:01,546 DIALSA THE LEVEL, AND THE 355 00:13:01,546 --> 00:13:03,748 TROAPINS AT THE LOWER PANEL, AT 356 00:13:03,748 --> 00:13:07,118 3 PHASES OF REPRODUCTIVE LIFE, 357 00:13:07,118 --> 00:13:08,786 DURING THE NORMAL REPRODUCTIVE 358 00:13:08,786 --> 00:13:10,421 LIFE CYCLE, THEN POST MENOPAUSE 359 00:13:10,421 --> 00:13:11,456 AND THEN THE TRANSITION FROM 360 00:13:11,456 --> 00:13:14,692 HERE TO HERE WHICH IS VARIABLY 361 00:13:14,692 --> 00:13:16,661 CALLED THE MENOPAUSE TRANSITION 362 00:13:16,661 --> 00:13:17,695 OR THE PERIMENOPAUSE, DURING THE 363 00:13:17,695 --> 00:13:20,498 COURSE OF THE NORMAL CYCLE, 364 00:13:20,498 --> 00:13:21,766 ESTRADISCIPLINARYOLE HAS THE BI 365 00:13:21,766 --> 00:13:24,902 PHASIC PATTERN OF SECRETION, AND 366 00:13:24,902 --> 00:13:28,039 SECRETION IS LARGELY CONFINED TO 367 00:13:28,039 --> 00:13:30,208 THE LUTEAL PHASE OF THE 368 00:13:30,208 --> 00:13:31,576 MENSTRUAL CYCLE. 369 00:13:31,576 --> 00:13:33,144 FSH INITIALLY INCREASES WHEN THE 370 00:13:33,144 --> 00:13:34,579 INIT FOLLICLE IS RECRUITED 371 00:13:34,579 --> 00:13:35,947 DURING THE EARLY FOLLICULAR 372 00:13:35,947 --> 00:13:40,518 PHASE AND BOTH HAVE PEAKS AROUND 373 00:13:40,518 --> 00:13:42,854 OUR APPROXIMATE TO OFULATION, 374 00:13:42,854 --> 00:13:44,255 DURING POST MENOPAUSE, ESTROIEN 375 00:13:44,255 --> 00:13:48,993 AND MENOPAUSE LEVELS ARE 376 00:13:48,993 --> 00:13:50,962 CONSISTENTLY LOW, WHEREAS FSH 377 00:13:50,962 --> 00:13:52,597 AND LH ARE TONICALLY ELEVATED 378 00:13:52,597 --> 00:13:54,332 AND YOU STOP SEEING THE 379 00:13:54,332 --> 00:13:55,967 PRODUCTION OF THESE HORMONES. 380 00:13:55,967 --> 00:13:57,902 THE TRANSITION IS QUITE A 381 00:13:57,902 --> 00:14:03,408 VARIABLE PERIOD, THERE ARE FEWER 382 00:14:03,408 --> 00:14:03,808 OFLATTORY CYCLES, 383 00:14:03,808 --> 00:14:04,475 ESTRADISCIPLINARYOLE LEVELS IN 384 00:14:04,475 --> 00:14:06,110 THE MAIORITY OF WOMEN BUT NOT 385 00:14:06,110 --> 00:14:07,645 ALL ARE ACTUALLY LOWER 386 00:14:07,645 --> 00:14:09,314 PROGRESSIVELY LOWER WITH KIND OF 387 00:14:09,314 --> 00:14:13,584 AN INCREASED DECLINE DURING THE 388 00:14:13,584 --> 00:14:18,623 LATE MENOPAUSE TRANSITION, FEWER 389 00:14:18,623 --> 00:14:24,896 OVULATTORY CYCLES FOR LESS 390 00:14:24,896 --> 00:14:25,396 PROGESTERONE. 391 00:14:25,396 --> 00:14:27,899 THE ELEVATED FSH LEVEL WAS 1 392 00:14:27,899 --> 00:14:29,067 MARKER THAT USED TO BE 393 00:14:29,067 --> 00:14:32,704 CONSIDERED AS PART OF SOME OF 394 00:14:32,704 --> 00:14:33,671 THE EARLY DEMONSTRATIONS OF 395 00:14:33,671 --> 00:14:36,441 RELATED TO A WOMAN'S 396 00:14:36,441 --> 00:14:38,576 REPRODUCTIVE AGING USED IN 397 00:14:38,576 --> 00:14:40,745 FERTILITY CLINICS AS WELL, WHERE 398 00:14:40,745 --> 00:14:45,149 SOME OF THE CRITERIA THAT WE'RE 399 00:14:45,149 --> 00:14:46,918 DEVELOPED TO IDENTIFY THE 400 00:14:46,918 --> 00:14:48,086 PERIMENOPAUSE EMPLOY THESE 401 00:14:48,086 --> 00:14:49,620 CRITERIA HAVE BEEN FORMALIZED IN 402 00:14:49,620 --> 00:14:51,122 THE STAGES OF REPRODUCTIVE AGING 403 00:14:51,122 --> 00:14:53,024 WORKSHOP AND SO THE MENOPAUSE 404 00:14:53,024 --> 00:14:55,026 TRANSITION WHICH IS THE TIME 405 00:14:55,026 --> 00:14:57,195 FROM REPRODUCTIVE TO THE POST 406 00:14:57,195 --> 00:14:59,831 MENOPAUSE IS CHARACTERIZED BY 407 00:14:59,831 --> 00:15:01,332 VARIABLE CYCLELING, SKIPPED 408 00:15:01,332 --> 00:15:03,234 PERIODS, OVER ALL AN ELEVATED 409 00:15:03,234 --> 00:15:05,636 FSH LEVELS AND THE PERIMENOPAUSE 410 00:15:05,636 --> 00:15:07,672 HAS BEEN DEFEIGNED AS THAT 411 00:15:07,672 --> 00:15:09,107 PERIOD OF THE TRANSITION PLUS 412 00:15:09,107 --> 00:15:12,276 THE FIRST YEAR AFTER THE LAST 413 00:15:12,276 --> 00:15:13,144 MENSTRUAL PERIOD. 414 00:15:13,144 --> 00:15:15,413 SO THIS REALLY KIND OF 415 00:15:15,413 --> 00:15:17,715 CHARACTERIZES THE ROLLER COASTER 416 00:15:17,715 --> 00:15:19,484 OF ENDOCRINE EVENTS THAT OCCUR 417 00:15:19,484 --> 00:15:20,451 DURING THE MENOPAUSE TRANSITION, 418 00:15:20,451 --> 00:15:22,520 AND THAT'S WHAT WE'RE FOCUSING 419 00:15:22,520 --> 00:15:25,957 ON ON IN OUR STUDIES RELATED TO 420 00:15:25,957 --> 00:15:26,524 DEPRESSION. 421 00:15:26,524 --> 00:15:29,961 SO, JUST AS A BACKGROUND, THE 422 00:15:29,961 --> 00:15:31,996 MENOPAUSE TRANSITION PROBABLY IS 423 00:15:31,996 --> 00:15:33,398 ABOUT--IT CAN LAST FROM ANYWHERE 424 00:15:33,398 --> 00:15:35,933 FROM 1 YEAR OR SHORTER, LIKE THE 425 00:15:35,933 --> 00:15:36,968 LAST NORMAL MENSTRUAL PERIOD 426 00:15:36,968 --> 00:15:40,037 COULD BE THE LAST MENSTRUAL 427 00:15:40,037 --> 00:15:40,438 PERIOD. 428 00:15:40,438 --> 00:15:42,840 IN OTHER WOMEN IT MAY GO ON FOR 429 00:15:42,840 --> 00:15:43,841 UP TO 15 YEARS. 430 00:15:43,841 --> 00:15:45,576 SO IT'S QUITE VARIABLE, IT'S A 431 00:15:45,576 --> 00:15:46,778 LOT OF INDIVIDUAL VARIATION FROM 432 00:15:46,778 --> 00:15:52,116 CYCLE TO CYCLE AND ALSO FROM 433 00:15:52,116 --> 00:15:52,784 WOMAN TO WOMAN. 434 00:15:52,784 --> 00:15:55,153 SO AS WE SUGGESTED THERE'S 435 00:15:55,153 --> 00:15:55,953 EPIDEMIOLOGIC EVIDENT TO 436 00:15:55,953 --> 00:15:57,121 SUGGIEST THAT FOR SOME WOMEN 437 00:15:57,121 --> 00:16:00,591 THIS, IS A PERIOD OF INCREASED 438 00:16:00,591 --> 00:16:01,559 RISK OF DEPRESSION. 439 00:16:01,559 --> 00:16:03,127 WHAT HASN'T BEEN ASKED IS 440 00:16:03,127 --> 00:16:05,196 WHETHER THERE'S DIFFERENCES IN 441 00:16:05,196 --> 00:16:06,230 REPRODUCTIVE FUNCTION THAT 442 00:16:06,230 --> 00:16:10,067 EITHER INCREASE THE RISK FOR OR 443 00:16:10,067 --> 00:16:10,902 ACCOMPANY PERIMENOPAUSAL 444 00:16:10,902 --> 00:16:11,202 DEPRESSION. 445 00:16:11,202 --> 00:16:12,069 OUR CROSS SECTIONAL STUDIES AND 446 00:16:12,069 --> 00:16:13,604 THOSE OF SEVERAL OTHER PEOPLE 447 00:16:13,604 --> 00:16:18,810 HAVE SHOWED THERE'S THOUGH 448 00:16:18,810 --> 00:16:19,777 BONAFIDE ENDOCRINE OPATHY, NO 449 00:16:19,777 --> 00:16:22,547 DEFICIENCY OR EXCESS OF ESTROGEN 450 00:16:22,547 --> 00:16:24,682 OR PROGESTERONE THAT 451 00:16:24,682 --> 00:16:26,083 DISTINGUISHES THESE WOMEN FROM 452 00:16:26,083 --> 00:16:27,819 REPRODUCTION FOR AGE AND MATCHED 453 00:16:27,819 --> 00:16:29,854 WOMAN WITHOUT DEPRESSION. 454 00:16:29,854 --> 00:16:31,956 AND THERE'S NO CHARACTERISTIC, 455 00:16:31,956 --> 00:16:34,091 INCLUDING HOT FLASHES THAT SEEM 456 00:16:34,091 --> 00:16:34,959 TO DISTINGUISH THIS GROUP. 457 00:16:34,959 --> 00:16:37,061 SO WE ASKED THE QUESTION IN OUR 458 00:16:37,061 --> 00:16:39,897 LONGITUDINAL STUDY, THIS IS DONE 459 00:16:39,897 --> 00:16:41,532 BY CONSTANT ZAO, A CLINICAL 460 00:16:41,532 --> 00:16:43,634 FELLOW IN THE BEHAVIORIAL 461 00:16:43,634 --> 00:16:44,902 ENDOKRENNOLOGY BRANCH AND SHE'S 462 00:16:44,902 --> 00:16:49,273 ANALYZED THIS DATA IN WHICH WE 463 00:16:49,273 --> 00:16:51,242 FOLLOWED PREMENOPAUSAL HEALTHY 464 00:16:51,242 --> 00:16:54,111 A-SYMPTOMATIC WOMEN, EVERY 6-8 465 00:16:54,111 --> 00:16:55,413 MONTHS, WE CONDUCTED VISITS 466 00:16:55,413 --> 00:16:56,647 DURING THE EARLY FOLLICULAR 467 00:16:56,647 --> 00:16:58,983 PHASE OF THE CYCLE UNTIL NAY 468 00:16:58,983 --> 00:17:00,651 WERE 6-12 MONTHS AFTER THE LAST 469 00:17:00,651 --> 00:17:01,552 MENSTRUAL PERIOD AND THIS WAS 470 00:17:01,552 --> 00:17:04,422 KIND OF A BEAR OF A STUDY. 471 00:17:04,422 --> 00:17:05,490 WE DID BLOOD HORMONE MEASURES 472 00:17:05,490 --> 00:17:09,760 AND I WILL BE FOCUSING ON FSH 473 00:17:09,760 --> 00:17:10,962 AND ESTRADISCIPLINARYOLE, AND 474 00:17:10,962 --> 00:17:12,196 PRELIMINARY DATA THAT CONSTANCE 475 00:17:12,196 --> 00:17:15,233 HAS ON THAT, AND PERFORMED 476 00:17:15,233 --> 00:17:16,200 DIAGNOSTIC INTERVIEWS IN ORDER 477 00:17:16,200 --> 00:17:17,502 TO EITHER CONFIRM THE PRESENCE 478 00:17:17,502 --> 00:17:19,403 OR ABSENCE OF THE DIN DROAM OF 479 00:17:19,403 --> 00:17:21,973 DEPRESSION AND IN SOME CASES 480 00:17:21,973 --> 00:17:24,909 BECAUSE IT'S PERSPECTIVELY 481 00:17:24,909 --> 00:17:26,444 MONITORED, THESE WOULD BE MINOR 482 00:17:26,444 --> 00:17:28,646 DEPRESSIONS, WE HAVE DAILY 483 00:17:28,646 --> 00:17:30,381 SYMPTOM RATINGS AS WELL AS 484 00:17:30,381 --> 00:17:31,582 CLINIC VISITS SO WE CAN 485 00:17:31,582 --> 00:17:33,050 UNDERSTAND THE PRODROAM. 486 00:17:33,050 --> 00:17:35,319 WE ALSO INCLAUDED A VARIETY OF 487 00:17:35,319 --> 00:17:37,088 MEASURES THAT HAD BEEN EITHER 488 00:17:37,088 --> 00:17:39,056 REPORTED TO ACCOMPANY DEPRESSION 489 00:17:39,056 --> 00:17:41,125 DURING MIDLIFE OR THE 490 00:17:41,125 --> 00:17:42,627 PERIMENOPAUSE AS WELL AS EVENTS 491 00:17:42,627 --> 00:17:47,198 THAT MIGHT CONTRIBUTE TO THE 492 00:17:47,198 --> 00:17:47,732 ONSET OF DEPRESSION. 493 00:17:47,732 --> 00:17:49,934 SO THIS IS A SPAGHETTI GRAPH OF 494 00:17:49,934 --> 00:17:52,436 THE 89 WOMEN WHO HAVE BEEN IN 495 00:17:52,436 --> 00:17:55,172 THIS STUDY THAT CONSTANCE IS 496 00:17:55,172 --> 00:17:57,441 ANALYZING, THE Y AXIS SHOWS THE 497 00:17:57,441 --> 00:17:59,176 NUMBER OF PARTICIPANTS. 498 00:17:59,176 --> 00:18:03,447 THE X-AXIS, THE LAST MENSTRUAL 499 00:18:03,447 --> 00:18:04,949 PERIOD IS MARKED BY THE DARK 500 00:18:04,949 --> 00:18:05,149 LINE. 501 00:18:05,149 --> 00:18:06,717 THE TIME BEFORE THAT ARE THE 502 00:18:06,717 --> 00:18:08,119 YEARS PRIOR TO THE LAST 503 00:18:08,119 --> 00:18:08,986 MENSTRUAL PERIOD AND THEN AFTER 504 00:18:08,986 --> 00:18:13,357 THAT ARE THE YEARS AFTER THE 505 00:18:13,357 --> 00:18:14,258 LAST MENSTRUAL PERIOD. 506 00:18:14,258 --> 00:18:16,894 EACH LINE WEP RESENTS A WOMEN'S 507 00:18:16,894 --> 00:18:20,197 COURSE THROUGH THE STUDY AND 508 00:18:20,197 --> 00:18:21,732 EACH DOTS REPRESENTS INDIVIDUAL 509 00:18:21,732 --> 00:18:23,834 CLINIC VISITS SO ON AVERAGE WE 510 00:18:23,834 --> 00:18:25,436 FOLLOWED EACH WOMAN FOR 511 00:18:25,436 --> 00:18:29,040 APPROXIMATELY 6 YEARS BUT 512 00:18:29,040 --> 00:18:31,375 CONSIDERABLY RAINCHL FROM 1-12.6 513 00:18:31,375 --> 00:18:35,713 YEARS, JUST TO FOCUS ON THE RED 514 00:18:35,713 --> 00:18:38,616 DOTS ARE THE WOMEN WHO REMAIN 515 00:18:38,616 --> 00:18:40,718 ASYMPTOMATIC DURING THE TRIAL 516 00:18:40,718 --> 00:18:42,620 AND BLUE DOTS ARE FOR THOSE WHO 517 00:18:42,620 --> 00:18:43,487 DEVELOP DEPRESSION AND WHEN WE 518 00:18:43,487 --> 00:18:45,656 FOUND IS A CLUSTERING OF 519 00:18:45,656 --> 00:18:46,090 DEPRESSIVE EPISODES. 520 00:18:46,090 --> 00:18:47,491 THESE ARE ALL THE EPISEDENTARYS 521 00:18:47,491 --> 00:18:48,793 OF DEPRESSION THAT OCCUR DURING 522 00:18:48,793 --> 00:18:51,429 THE TRIAL IN EACH OF THESE 523 00:18:51,429 --> 00:18:51,629 WOMEN. 524 00:18:51,629 --> 00:18:53,464 AND THERE WAS A CLUSTERING, THE 525 00:18:53,464 --> 00:18:55,866 Y-AXIS IS THE NUMBER OF 526 00:18:55,866 --> 00:18:57,702 DEPRESSIVE EPISODES IN THE 527 00:18:57,702 --> 00:19:01,973 AGAIN, IT'S PREAND POST LAST 528 00:19:01,973 --> 00:19:04,108 MENS, AND THIS IS OCCURRING 529 00:19:04,108 --> 00:19:06,777 DURING THE 24 MONTHS SURROUNDING 530 00:19:06,777 --> 00:19:08,312 THE LAST MENSTRUAL PERIOD AS 531 00:19:08,312 --> 00:19:09,914 WELL AS EPISODES THAT OCCURRED 532 00:19:09,914 --> 00:19:11,582 PRIOR TO THAT BUT WHAT WERE 533 00:19:11,582 --> 00:19:12,550 HIGHLIGHTED IN PINK ARE THE 1S 534 00:19:12,550 --> 00:19:15,586 THAT OCCURRED IN THE YEAR BEFORE 535 00:19:15,586 --> 00:19:18,022 OR AFTER THE LAST MENSTRUAL 536 00:19:18,022 --> 00:19:23,361 PERIOD. 537 00:19:23,361 --> 00:19:24,795 AND WE IDENTIFIED 29 EPISODES IN 538 00:19:24,795 --> 00:19:25,296 22 WOMEN. 539 00:19:25,296 --> 00:19:27,665 WENT OF THESE OCCURRED IN THE 24 540 00:19:27,665 --> 00:19:28,833 MONTHS SURROUNDING THE LAST 541 00:19:28,833 --> 00:19:31,769 MENSTRUAL PERIOD AS A MENTIONED. 542 00:19:31,769 --> 00:19:35,406 IN 19 OF THESE 20 WOMEN THAT 543 00:19:35,406 --> 00:19:38,476 EVEN IF THEY DIDN'T OCCUR DURING 544 00:19:38,476 --> 00:19:40,678 THAT PERIOD OF THE 2 YEARS 545 00:19:40,678 --> 00:19:42,313 AROUND LAST MENSTRUAL PERIOD, 546 00:19:42,313 --> 00:19:45,149 THE EPISODE OF DEPRESSION 547 00:19:45,149 --> 00:19:48,819 OCCURRED AFTER WE IDENTIFIED AND 548 00:19:48,819 --> 00:19:51,022 ELVITTED PLASMA FSH LEVELS 549 00:19:51,022 --> 00:19:53,224 SUGGIESTING THAT THE 550 00:19:53,224 --> 00:19:54,058 REPRODUCKIVE AGING PROCESS 551 00:19:54,058 --> 00:19:57,495 PRESEED THE ONSET OF THE 552 00:19:57,495 --> 00:19:57,862 DEPRESSION. 553 00:19:57,862 --> 00:20:00,564 FINALLY, ONLY 4 WOMEN IN THIS 554 00:20:00,564 --> 00:20:02,633 COHORT HAD A PREVIOUS PATH MAJOR 555 00:20:02,633 --> 00:20:06,637 DEPRESSION, SO 18 OF THESE 22, 556 00:20:06,637 --> 00:20:08,939 WOMEN HAD A FIRST ONSET OF 557 00:20:08,939 --> 00:20:11,876 DEPRESSION IN THE PERIMENOPAUSE. 558 00:20:11,876 --> 00:20:14,445 SO LOOKING AT THEIR PLASMA 559 00:20:14,445 --> 00:20:15,012 ESTRADISCIPLINARYOLE LEVELS 560 00:20:15,012 --> 00:20:19,250 SHOWN IN THIS GRAPH AND I 561 00:20:19,250 --> 00:20:21,052 APOLOGIZE, THERE'S POTENTIAL 562 00:20:21,052 --> 00:20:22,019 CONFUSION WHERE THAL CASE, THE 563 00:20:22,019 --> 00:20:23,988 BLUE LINE ARE THE WOMEN WHO DID 564 00:20:23,988 --> 00:20:25,189 NOT EXPERIENCE DEPRESSION, SO 565 00:20:25,189 --> 00:20:27,825 THESE ARE--THESE ARE THE 566 00:20:27,825 --> 00:20:28,926 ASYMPTOMATEC WOMEN, THE RED LINE 567 00:20:28,926 --> 00:20:32,496 IS IN THIS CASE, THE WOMEN WHO 568 00:20:32,496 --> 00:20:33,998 DID DEVELOP DEPRESSION AND THIS 569 00:20:33,998 --> 00:20:36,367 SHOWS THE PATTERN OF 570 00:20:36,367 --> 00:20:37,668 ESTRADISCIPLINARYOLE SECRETION 571 00:20:37,668 --> 00:20:39,603 ALONG WITH 95% CONFIDENCE 572 00:20:39,603 --> 00:20:40,771 INTERVAL BAN OVER THE COURSE OF 573 00:20:40,771 --> 00:20:42,206 THE STUDY AND IT'S ANCHORED 574 00:20:42,206 --> 00:20:44,942 RELATIVE TO THE LAST MENSTRUAL 575 00:20:44,942 --> 00:20:45,176 PERIOD. 576 00:20:45,176 --> 00:20:50,381 AND WHAT WE FOUND IS SIGNIFICANT 577 00:20:50,381 --> 00:20:51,949 THESE PRELIMINARY DATA 578 00:20:51,949 --> 00:20:53,284 SUGGESTING IGF 95 CANT EFFECTS 579 00:20:53,284 --> 00:20:54,885 INTERACTION BETWEEN TIME AND THE 580 00:20:54,885 --> 00:20:56,387 ONSET OF DEPRESSION AND THAT 581 00:20:56,387 --> 00:20:57,455 THESE WERE DEMON TRAITED WITH 582 00:20:57,455 --> 00:21:00,057 THE WOMEN WHO DEVELOPED 583 00:21:00,057 --> 00:21:03,627 DEPRESSION HAD AN EARLIER PEAK 584 00:21:03,627 --> 00:21:04,995 DURING THE MENOPAUSE TRANSITION 585 00:21:04,995 --> 00:21:08,132 AND A HIGHER LEVEL OF 586 00:21:08,132 --> 00:21:09,366 ESTRADISCIPLINARYOLE SECRETION 587 00:21:09,366 --> 00:21:11,402 COMPARED WITH THE CONTROLS WHO 588 00:21:11,402 --> 00:21:15,005 PEAKED APPROXIMATELY A YEAR 589 00:21:15,005 --> 00:21:15,606 LATER. 590 00:21:15,606 --> 00:21:20,010 THIS IS HAPPENING, AGAIN, 591 00:21:20,010 --> 00:21:20,878 THOUGH, APPROXIMATELY 5-6 YEARS 592 00:21:20,878 --> 00:21:23,280 WHEREAS WE'RE SEEING THE 593 00:21:23,280 --> 00:21:25,182 CLUSTERING OF DEPRESSIVE 594 00:21:25,182 --> 00:21:26,851 EPISODES IN THE YEAR OR SO AFTER 595 00:21:26,851 --> 00:21:27,918 THE LAST MENSTRUAL PERIOD, SO 596 00:21:27,918 --> 00:21:29,186 THESE ARE THINGS THAT ARE 597 00:21:29,186 --> 00:21:30,921 HAPPENING BEFORE HAND THAT WE 598 00:21:30,921 --> 00:21:33,224 WOULDN'T CAPTURE IN OUR CLINIC 599 00:21:33,224 --> 00:21:35,292 WHEN WE'RE EVALUATING WOMEN 600 00:21:35,292 --> 00:21:36,327 CROSS SECTIONALLY. 601 00:21:36,327 --> 00:21:38,062 THE 2 LINES MEET ABOUT A YEAR 602 00:21:38,062 --> 00:21:40,664 BEFORE THE FINAL MENSTRUAL 603 00:21:40,664 --> 00:21:42,633 PERIOD AND BEGAN TO SEPARATE. 604 00:21:42,633 --> 00:21:44,235 SO THESE DATA SUGGEST A MORE 605 00:21:44,235 --> 00:21:46,604 EARLIER PEAK AND A MORE RAPID 606 00:21:46,604 --> 00:21:47,238 DECLINE OF ESTRADISCIPLINARYOLE 607 00:21:47,238 --> 00:21:49,640 IN THE WOMEN WHO DEVELOP 608 00:21:49,640 --> 00:21:50,941 DEPRESSION DURING THE 609 00:21:50,941 --> 00:21:52,209 PERIMENOPAUSE, THE FSH LEVELS 610 00:21:52,209 --> 00:21:54,879 SHOWING THE SAME SET UP WITH THE 611 00:21:54,879 --> 00:21:57,848 FSH, LEVELS AND THE 95% 612 00:21:57,848 --> 00:21:59,550 CONFIDENCE BANS FOR THE 613 00:21:59,550 --> 00:22:03,220 DEPRESSED WOMEN IN RED AND THE 614 00:22:03,220 --> 00:22:04,455 IEE, AUDIENCE SYMPTOMATIC WOMEN 615 00:22:04,455 --> 00:22:07,925 IN BLUE, THAT AGAIN, WE FOUND 616 00:22:07,925 --> 00:22:08,659 SIGNIFICANT EFFECTS OF 617 00:22:08,659 --> 00:22:10,227 INTERACTIONS BETWEEN TIME AND 618 00:22:10,227 --> 00:22:12,263 THE DIAGNOSIS OF DEPRESSION 619 00:22:12,263 --> 00:22:14,632 WHERE THERE WERE HIGHER FSH 620 00:22:14,632 --> 00:22:16,700 LEVELS, VERY EARLY ON IN THE 621 00:22:16,700 --> 00:22:18,402 MENOPAUSE TRANSITION, IN THE 622 00:22:18,402 --> 00:22:20,571 WOMEN WHO DEVELOP DEPRESSION AS 623 00:22:20,571 --> 00:22:22,907 WELL AS A STEEPER PEEK INCREASE 624 00:22:22,907 --> 00:22:26,043 THAT MAY CORRESPOND WITH THE 625 00:22:26,043 --> 00:22:27,945 MORE STEEPER DECLINE OF 626 00:22:27,945 --> 00:22:28,546 ESTRADISCIPLINARYOLE, REMEMBER 627 00:22:28,546 --> 00:22:29,914 THESE 2 HORMONES ARE KIND OF IN 628 00:22:29,914 --> 00:22:32,917 A LITTLE BIT OF A RECIPROCAL 629 00:22:32,917 --> 00:22:34,952 RELATIONSHIP WITH EACH OTHER 630 00:22:34,952 --> 00:22:36,954 PRIOR TO THE LAST MENSTRUAL 631 00:22:36,954 --> 00:22:38,622 PERIOD. 632 00:22:38,622 --> 00:22:40,691 SO, THESE DATA SUGGEST THAT ARE 633 00:22:40,691 --> 00:22:45,529 MAY ACTUALLY BE SOME HORMONAL 634 00:22:45,529 --> 00:22:47,932 ANTISEEDENTS OR ACCOMPANIMENTS 635 00:22:47,932 --> 00:22:48,599 OF PERIMENOPAUSAL DEPRESSION BUT 636 00:22:48,599 --> 00:22:50,334 MOST OF THEM ARE OCCURRING 637 00:22:50,334 --> 00:22:51,902 BEFORE THE ONSET OF DEPRESSION. 638 00:22:51,902 --> 00:22:55,005 SO THIS MAY BE SOMETHING THAT WE 639 00:22:55,005 --> 00:22:58,742 CAN, IF CONFIRMED IN THE FINAL 640 00:22:58,742 --> 00:23:00,110 DATA, MAY GIVE US SOME MEASURE 641 00:23:00,110 --> 00:23:02,279 OF WHAT MIGHT BE HAPPENING PRIOR 642 00:23:02,279 --> 00:23:04,148 TO I WOMAN EXPERIENCING 643 00:23:04,148 --> 00:23:05,416 DEPRESSION DURING THE MENOPAUSE 644 00:23:05,416 --> 00:23:07,484 TRANSITION THAT WILL GIVE US 645 00:23:07,484 --> 00:23:10,621 SOME MARKERS OF RISK. 646 00:23:10,621 --> 00:23:12,523 SO GOING BACK TO WHAT WE TALKED 647 00:23:12,523 --> 00:23:14,391 ABOUT, IS THAT THE MENOPAUSE 648 00:23:14,391 --> 00:23:17,595 TRANSITION, WE SEE THE EPISODES 649 00:23:17,595 --> 00:23:18,429 CLUSTER DURING THE LATE 650 00:23:18,429 --> 00:23:19,597 TRANSITION WHICH IS A TAME AS 651 00:23:19,597 --> 00:23:20,931 WELL AS SEVERAL OTHER STUDIES 652 00:23:20,931 --> 00:23:23,000 SHOWING THIS, THAT IT'S A TIME 653 00:23:23,000 --> 00:23:25,870 OF KIND OF THE MOST--THE 654 00:23:25,870 --> 00:23:27,571 GREATEST DECLINES IN ESTRO 655 00:23:27,571 --> 00:23:28,038 DISCIPLINARYOLE LEVEL. 656 00:23:28,038 --> 00:23:30,674 WE ALSO KNOW FROM SEVERAL 657 00:23:30,674 --> 00:23:32,810 STUDIES THAT 658 00:23:32,810 --> 00:23:35,613 ESTRADISCIPLINARYOLE MAY HAVE 659 00:23:35,613 --> 00:23:37,114 BOTH ACUTE ANTIDEPRESS ABT LIKE 660 00:23:37,114 --> 00:23:43,621 EFFECTS AS WELL AS PREVENTATIVE 661 00:23:43,621 --> 00:23:44,421 PERIMENOPAUSAL DEPRESSION 662 00:23:44,421 --> 00:23:47,291 SYMPTOMS AACCORDING TO A STUDY 663 00:23:47,291 --> 00:23:47,992 BY JENNIFER GORDON. 664 00:23:47,992 --> 00:23:51,428 SO WE ASKED WHETHER THIS 665 00:23:51,428 --> 00:23:52,129 PRECIPITATES DEPRESSION IN WOMEN 666 00:23:52,129 --> 00:23:54,632 WITH A HISTORY OF PAST 667 00:23:54,632 --> 00:23:54,932 DEPRESSION? 668 00:23:54,932 --> 00:23:57,501 SO THOSE WOMEN WE KNOW ARE 669 00:23:57,501 --> 00:23:58,202 VULNERABLE TO DEVELOPING 670 00:23:58,202 --> 00:23:59,436 DEPRESSION, WHAT ARE THE EFFECTS 671 00:23:59,436 --> 00:24:00,704 ON MOOD COMPARED TO WOMEN WHO 672 00:24:00,704 --> 00:24:02,239 DID NOT DEVELOP A DEPRESSION, SO 673 00:24:02,239 --> 00:24:03,874 THIS IS THE SCHEMATIC DESIGN OF 674 00:24:03,874 --> 00:24:06,543 THAT STUDY, WE RECRUITED WOMEN 675 00:24:06,543 --> 00:24:09,313 WHO HAD REPORTED ON HOW TO WELL 676 00:24:09,313 --> 00:24:11,315 CHARACTERIZE DEPRESSION DURING 677 00:24:11,315 --> 00:24:12,182 THE PERIMENOPAUSE. 678 00:24:12,182 --> 00:24:14,718 THEY WERE NOW POST MENOPAUSE AND 679 00:24:14,718 --> 00:24:16,120 HAD A REMISSION OF THE 680 00:24:16,120 --> 00:24:18,422 DEPRESSION OR IT STARTED SOME 681 00:24:18,422 --> 00:24:19,223 FORM OF THERAPY. 682 00:24:19,223 --> 00:24:20,758 THEY WERE TAKEN OFF THEIR 683 00:24:20,758 --> 00:24:23,260 CURRENT MEDS AND PLACED ON A 684 00:24:23,260 --> 00:24:24,428 STANDARD LEVEL OF 685 00:24:24,428 --> 00:24:26,163 ESTRADISCIPLINARYOLE AND A 686 00:24:26,163 --> 00:24:27,665 HUNDRED MICROGRAMS A DAY GIVEN 687 00:24:27,665 --> 00:24:29,767 BY SKIN PATCH FOR 3 WEEKS. 688 00:24:29,767 --> 00:24:31,835 AFTER 3 WEEKS, HALF THE GROUP 689 00:24:31,835 --> 00:24:34,905 CONTINUED ON THE SAME DOSE OF 690 00:24:34,905 --> 00:24:35,539 ESTRADISCIPLINARYOLE, WHAZ THE 691 00:24:35,539 --> 00:24:37,975 OTHER HALF OF THE WOMEN WERE 692 00:24:37,975 --> 00:24:40,311 CROSS TD OVER TO PLACEBO 693 00:24:40,311 --> 00:24:40,544 PATCHES. 694 00:24:40,544 --> 00:24:51,021 SO IF THERE WAS GOING TO BE 695 00:25:06,070 --> 00:25:08,739 EVIDENCE OF. 696 00:25:08,739 --> 00:25:11,809 --SO THEY EXPERIENCED BOTH THE 697 00:25:11,809 --> 00:25:13,377 SAME DOSES OF ESTRADIOL, 698 00:25:13,377 --> 00:25:14,845 PRESUMABLY HAD A CHANGE IN 699 00:25:14,845 --> 00:25:16,013 HORMONE MOANS IN THE 1 WHO IS 700 00:25:16,013 --> 00:25:17,047 WENT THROUGH THE WITHDRAWAL 701 00:25:17,047 --> 00:25:18,515 EMPLOY THIS IS AN EXAMPLE OF THE 702 00:25:18,515 --> 00:25:20,818 RESULTS WE SAW, THIS IS SCORES 703 00:25:20,818 --> 00:25:24,088 ON THE Y-AXIS OR THE CENTERS FOR 704 00:25:24,088 --> 00:25:24,822 EPIDEMIOLOGIC DEPRESSION STUDY 705 00:25:24,822 --> 00:25:26,423 SCALE WHERE HIGHER SCORES 706 00:25:26,423 --> 00:25:29,994 REPRESENT MORE SEVERE DEPRESSIVE 707 00:25:29,994 --> 00:25:30,427 SYMPTOMS. 708 00:25:30,427 --> 00:25:33,297 Y-AXIS EACH OF THESE BARS 709 00:25:33,297 --> 00:25:33,964 REPRESENT THE AVERAGE SCORE IN 710 00:25:33,964 --> 00:25:36,700 THE WOMEN WHO WERE IN THAT GROUP 711 00:25:36,700 --> 00:25:38,936 FOR EACH OF THEIR CLINIC VISITS 712 00:25:38,936 --> 00:25:40,704 DURING THE 6 WEEKS OF THE TRIAL. 713 00:25:40,704 --> 00:25:42,106 FOCUSING ON THE GROUP IN THE 714 00:25:42,106 --> 00:25:44,975 MIDDLE, THESE ARE THE WOMEN WITH 715 00:25:44,975 --> 00:25:50,014 PAST PERIMENOPAUSAL DEPRESSION 716 00:25:50,014 --> 00:25:54,485 WHO WHEN THEY WITHDREW 717 00:25:54,485 --> 00:25:58,589 EXPERIENCED RECURRENCE OF 718 00:25:58,589 --> 00:25:59,857 SYMPTOMS, IN CONTRAST TO THESE 719 00:25:59,857 --> 00:26:01,291 WOMEN WHO CONTINUE OFFICE OF 720 00:26:01,291 --> 00:26:01,859 DIVERSITY ESTRADISCIPLINARY 721 00:26:01,859 --> 00:26:03,994 OLDER PEOPLE BUT HAD THE SAME 722 00:26:03,994 --> 00:26:05,162 PAST HISTORY BUT COMPEARED TO 723 00:26:05,162 --> 00:26:06,530 THE CONTROL WOMEN WHEN 724 00:26:06,530 --> 00:26:07,131 EXPERIENCED NO SUBSTANTIAL 725 00:26:07,131 --> 00:26:09,867 CHANGE IN MOOD WHEN THEY 726 00:26:09,867 --> 00:26:13,037 UNDERWENT AN IDENTICAL HORMONE 727 00:26:13,037 --> 00:26:13,404 WITHDRAWAL. 728 00:26:13,404 --> 00:26:16,006 SO THESE DATA DOCUMENT THIS 729 00:26:16,006 --> 00:26:18,042 DIFFERENTIAL SENSITIVITY WE TALK 730 00:26:18,042 --> 00:26:19,443 ABOUT WHERE AND OTHERWISE IESHES 731 00:26:19,443 --> 00:26:22,880 DENTICAL CHANGE IN HORMONE WILL 732 00:26:22,880 --> 00:26:25,115 HAVE THE KASP A R PASQUANTINOITY 733 00:26:25,115 --> 00:26:26,617 OF INDUCING NEG5 MOOD STATES IN 734 00:26:26,617 --> 00:26:28,719 SOME WOMEN WHEN ARE OTHERWISE 735 00:26:28,719 --> 00:26:30,220 VULNERABILITY BUT NOT THE 736 00:26:30,220 --> 00:26:31,021 MAJORITY OF WOMEN. 737 00:26:31,021 --> 00:26:33,657 WE'RE PURSUING THIS QUESTION NOW 738 00:26:33,657 --> 00:26:37,728 IN A TRIAL, ASK WHETHER THE 739 00:26:37,728 --> 00:26:38,929 ASHINGS OF ESTROGEN WITHDRAWAL 740 00:26:38,929 --> 00:26:41,331 ARE MEDIATED BY E. R. BETA. 741 00:26:41,331 --> 00:26:43,434 SO WHY E. R. BETA. 742 00:26:43,434 --> 00:26:45,836 THIS WAS A SECOND ESTRAGENERATED 743 00:26:45,836 --> 00:26:49,273 THAT WAS CLONED BY CANNED WHAT, 744 00:26:49,273 --> 00:26:51,308 AND [INDISCERNIBLEA IN 1996 AT 745 00:26:51,308 --> 00:26:53,177 THE [INDISCERNIBLE]. 746 00:26:53,177 --> 00:26:56,013 AND IT'S ENCODED ON A SEPARATE 747 00:26:56,013 --> 00:27:00,184 CHROMOSOME THAN THE ORIGINAL 748 00:27:00,184 --> 00:27:01,718 ER-ALPHA CHROMOSOME 6 AND 14 749 00:27:01,718 --> 00:27:03,954 RESPECTIVELY WITH 6 BEING FOR 750 00:27:03,954 --> 00:27:06,523 ER-ALPHA AND 14 FOR ER-BETA. 751 00:27:06,523 --> 00:27:11,161 SO THEY MAY BE UNDER DIFFERENT 752 00:27:11,161 --> 00:27:12,029 EVOLUTIONARY PRESSURES EMPLOY 753 00:27:12,029 --> 00:27:13,764 WHAT ER BETA IS OF INTEREST 754 00:27:13,764 --> 00:27:15,265 STHAT IT SEEMS TO BE MORE 755 00:27:15,265 --> 00:27:16,567 RELEVANT FOR SOME OF THE BRAIN 756 00:27:16,567 --> 00:27:19,603 AFFECTS THAT WE'RE LOOKING AT 757 00:27:19,603 --> 00:27:21,438 AND IT IS KIND DIFREPRESENTIALLY 758 00:27:21,438 --> 00:27:24,041 LOCALIZED IN THE BRAIN AND 759 00:27:24,041 --> 00:27:27,177 PREFRONTAL CORTEX, TEMPORAL 760 00:27:27,177 --> 00:27:30,414 LOBES, IT ALSO, IN AN STUDIES 761 00:27:30,414 --> 00:27:32,549 HAVE BEEN SHOWN TO MODEIATE THE 762 00:27:32,549 --> 00:27:34,051 EFFECTS OF ESTRADIOL ON A RANGE 763 00:27:34,051 --> 00:27:36,019 OF AFFECTIVE LIKE BEHAVIORS AS 764 00:27:36,019 --> 00:27:38,755 WELL AS REGULATING THE STRESS 765 00:27:38,755 --> 00:27:40,357 RESPONSE IN PARTICULARLY HPA 766 00:27:40,357 --> 00:27:41,525 ACCESS FUNCTION. 767 00:27:41,525 --> 00:27:43,360 SO WHEN WE THOUGHT WAS WHETHER 768 00:27:43,360 --> 00:27:46,363 WE KNOW THAT ER ALPHA PREVENTS 769 00:27:46,363 --> 00:27:47,131 THE WITHDRAWAL EFFECTS, WHAT WE 770 00:27:47,131 --> 00:27:50,767 WANT TO LOOK AT IS WHETHER 771 00:27:50,767 --> 00:27:52,302 SCHECT OFLY ER BETA MAY PREVENT 772 00:27:52,302 --> 00:27:54,104 THESE BECAUSE 1 OF THE THINGS IS 773 00:27:54,104 --> 00:27:55,339 SINCE THE WOMEN'S HEALTH 774 00:27:55,339 --> 00:27:56,940 INITIATIVE, THERE HAS BEEN A 775 00:27:56,940 --> 00:28:00,144 CONCERN AMONGST WOMEN AND THEIR 776 00:28:00,144 --> 00:28:01,745 GYNECOLOGISTS ABOUT USING 777 00:28:01,745 --> 00:28:03,680 ESTROGEN THERAPY ALTHOUGH THAT 778 00:28:03,680 --> 00:28:05,949 PENDULUM IS SWINGING BACK 779 00:28:05,949 --> 00:28:07,484 SOMEWHAT BUT CERTAINLY ER BETA 780 00:28:07,484 --> 00:28:08,819 COULD AFFORD A MORE TARGETED 781 00:28:08,819 --> 00:28:10,220 THERAPY ON SOME OF THE BRAIN 782 00:28:10,220 --> 00:28:13,991 CONDITIONS THAT WE'RE LOOKING AT 783 00:28:13,991 --> 00:28:16,160 WHETHER IT'S MOOD OR COGNITION,A 784 00:28:16,160 --> 00:28:18,795 WELL BECAUSE OF ITS LACK OF 785 00:28:18,795 --> 00:28:20,831 EFFECTS ON THE ENDOMETRIUM, ER 786 00:28:20,831 --> 00:28:23,167 BETA MAY HAVE A LONGER TERM 787 00:28:23,167 --> 00:28:25,736 SAFETY PROFILE THAN TYPICAL 788 00:28:25,736 --> 00:28:26,904 ESTROGEN THERAPY. 789 00:28:26,904 --> 00:28:29,439 SO THIS STUDY UNFORTUNATELY OR 790 00:28:29,439 --> 00:28:30,941 FORTUNATELY IS ALMOST FINERBED 791 00:28:30,941 --> 00:28:32,709 BUT NOT FINISHED AS OF YET. 792 00:28:32,709 --> 00:28:34,678 WE HAVE ABOUT 5 MORE WOMEN TO 793 00:28:34,678 --> 00:28:36,480 RECRUIT FOR THIS STUDY AND WHAT 794 00:28:36,480 --> 00:28:39,016 WE DO IS WE RECRUIT WOMEN 795 00:28:39,016 --> 00:28:43,854 SIMILAR TO THE ESTROGEN 796 00:28:43,854 --> 00:28:44,354 WITHDRAWAL STUDY. 797 00:28:44,354 --> 00:28:46,256 THEY ARE PLACED ON A STANDARD 798 00:28:46,256 --> 00:28:48,792 DOSE OF ESTRADIOL AND AFTER 3 799 00:28:48,792 --> 00:28:50,661 WEEKS, A THIRD OF THEM ARE 800 00:28:50,661 --> 00:28:52,129 CROSSED OVER TO PLACEBO WHICH 801 00:28:52,129 --> 00:28:52,796 WOULD BE THE WITHDRAWAL PERIOD 802 00:28:52,796 --> 00:28:54,731 AND THEN THE OTHER 2/3RDS 803 00:28:54,731 --> 00:28:57,601 RECEIVE 1 OF 2 DOSES OF THIS 804 00:28:57,601 --> 00:29:00,604 LYINTAIZ COMPOUND WHICH IS THE 805 00:29:00,604 --> 00:29:02,139 ESTROGEN RECEPTOR BETA AGONIST. 806 00:29:02,139 --> 00:29:05,108 WE USE 2 DIFFERENT DOSES TO BOTH 807 00:29:05,108 --> 00:29:07,744 LOOK AT IMPACT AND INCREASED 808 00:29:07,744 --> 00:29:09,479 PENETRATION TO THE BRAIN WHERE 809 00:29:09,479 --> 00:29:11,682 THAT'S BEEN A PROBLEM FOR SOME 810 00:29:11,682 --> 00:29:14,151 OF THE PREVIOUS ESTROGEN 811 00:29:14,151 --> 00:29:16,753 RECEPTOR AGONIST, IT COMPLICATES 812 00:29:16,753 --> 00:29:19,523 THINGS A LITTLE BIT BECAUSE THE 813 00:29:19,523 --> 00:29:21,825 OPTIMAL DOSE FOR SELECTIVITY FOR 814 00:29:21,825 --> 00:29:24,161 ER BETA VERSUS ER ALPHA IS AT 815 00:29:24,161 --> 00:29:25,262 LOWER DOSES SO WE HAVE TO 816 00:29:25,262 --> 00:29:26,897 INCLUDE A NUMBER OF THINGS WE'RE 817 00:29:26,897 --> 00:29:31,668 DOING IN COLLABORATION WITH ALAN 818 00:29:31,668 --> 00:29:33,604 [INDISCERNIBLE] TO MONITOR 819 00:29:33,604 --> 00:29:35,005 ER-ALPHA FEESKTS IN THESE WOMEN, 820 00:29:35,005 --> 00:29:39,343 SO WE CAN BE CERTAIN THAT WE CAN 821 00:29:39,343 --> 00:29:40,744 SAY PREDOMINANTLY, AND WHAT WE 822 00:29:40,744 --> 00:29:42,379 HAVE SEEN, IS THAT IN SOME OF 823 00:29:42,379 --> 00:29:45,882 OUR WOMEN, WE HAVE BEEN ABLE TO 824 00:29:45,882 --> 00:29:47,084 REPLICATE THE ESTRO GENERATED 825 00:29:47,084 --> 00:29:47,551 WITHDRAWAL. 826 00:29:47,551 --> 00:29:49,620 THESE ARE CSD SCORES SO THIS 827 00:29:49,620 --> 00:29:50,687 WOMEN FOR EXAMPLE, WHO MAY OR 828 00:29:50,687 --> 00:29:53,624 MAY NOT HAVE BEEN ON PLACEBO, 829 00:29:53,624 --> 00:29:56,727 BUT REGARDLESS, SHE DID 830 00:29:56,727 --> 00:29:59,062 EXPERIENCE A RECURRENCE OF HER 831 00:29:59,062 --> 00:30:00,897 MOOD SYMPTOMS OR IN THE CONTEXT 832 00:30:00,897 --> 00:30:01,932 OF THE DOUBLE BLIND. 833 00:30:01,932 --> 00:30:08,005 SO WE ARE AT LEAST ABLE TO DO 834 00:30:08,005 --> 00:30:09,373 THE--OR REPLICATE THE SIGNAL AND 835 00:30:09,373 --> 00:30:11,275 WE'RE HOPING NOW TO SEE THAT IN 836 00:30:11,275 --> 00:30:13,710 A COUPLE MONTHS WHAT THE EFFECTS 837 00:30:13,710 --> 00:30:17,314 OF ER-BETA MAY OR MAY NOT BE. 838 00:30:17,314 --> 00:30:19,883 SO IN THE LAST PART OF MY TALK I 839 00:30:19,883 --> 00:30:21,451 WANT TO FOCUS ON SOME OF OUR 840 00:30:21,451 --> 00:30:22,519 INVITRO STUDIES WE HAVE DONE TO 841 00:30:22,519 --> 00:30:24,921 ASK THE QUESTION ABOUT WHAT 842 00:30:24,921 --> 00:30:26,290 GIVES WITH THE DIFFERENCE 843 00:30:26,290 --> 00:30:28,959 BETWEEN THE WOMEN WITH PAST 844 00:30:28,959 --> 00:30:30,060 PERIMENOPAUSAL DEPRESSION WHO 845 00:30:30,060 --> 00:30:31,928 EXPERIENCE RECURRENCE AND THE 846 00:30:31,928 --> 00:30:34,531 CONTROLS WHO ARE OTHERWISE 847 00:30:34,531 --> 00:30:35,832 IDENTICAL EXCEPT THEY DID NOT 848 00:30:35,832 --> 00:30:38,702 HAVE A HISTORY OF DEPRESSION 849 00:30:38,702 --> 00:30:39,836 EITHER DURING THE PERIMENOPAUSE 850 00:30:39,836 --> 00:30:41,605 OR AT ANY OTHER TIME IN THEIR 851 00:30:41,605 --> 00:30:43,240 LIFE, SO THIS IS WORK THAT'S 852 00:30:43,240 --> 00:30:44,508 DONE IN COLLABORATION, THIS IS 853 00:30:44,508 --> 00:30:47,911 WORK DONE BY SARAH 854 00:30:47,911 --> 00:30:48,845 [INDISCERNIBLE], A FELLOW IN OUR 855 00:30:48,845 --> 00:30:50,614 GROUP AS WELL AS IN 856 00:30:50,614 --> 00:30:52,749 COLLABORATION WITH DAVID GOLDMAN 857 00:30:52,749 --> 00:30:55,752 AT THE LAB OF NEUROGENETICS AT 858 00:30:55,752 --> 00:30:55,952 NIAAA. 859 00:30:55,952 --> 00:30:59,656 AND WHAT WE WANTED TO ASK WAS 860 00:30:59,656 --> 00:31:00,957 GIVEN THAT STEROIDS ACT THROUGH 861 00:31:00,957 --> 00:31:01,758 THE NUCLEAR MEMORY RESPONSE 862 00:31:01,758 --> 00:31:03,293 BREAN IN LARGE PART IS WHETHER 863 00:31:03,293 --> 00:31:06,697 THERE'S A DRVES IN THE CELLULAR 864 00:31:06,697 --> 00:31:08,198 MECHANISM UNDERLYING THIS 865 00:31:08,198 --> 00:31:10,300 DIFFERENTIAL BEHAVIOR RESPONSE 866 00:31:10,300 --> 00:31:11,635 TO ESTROGEN WITHDRAWAL. 867 00:31:11,635 --> 00:31:14,771 SO WHAT SARAH DID WAS TRY TO 868 00:31:14,771 --> 00:31:16,273 RECAPITULATE THE CLINICAL SPRMS 869 00:31:16,273 --> 00:31:17,674 THAT WE'RE DOING IN THESE WOMEN 870 00:31:17,674 --> 00:31:21,011 BY TAKING CELLS FROM THEM AND 871 00:31:21,011 --> 00:31:23,714 TRYING TO EXPOSE THEM TO 872 00:31:23,714 --> 00:31:25,015 ESTROGEN OR ESTROGEN WITHDRAWAL. 873 00:31:25,015 --> 00:31:27,317 SO WE RECRUITED IN THE FIRST 874 00:31:27,317 --> 00:31:28,618 COHORT, WE RECRUITED WOMEN WHO 875 00:31:28,618 --> 00:31:30,587 WERE SERVED AS CONTROLS IN THE 876 00:31:30,587 --> 00:31:32,155 ESTARE GEN WITHDRAWAL STUDY, OR 877 00:31:32,155 --> 00:31:33,990 WERE IN THE PERIMENOPAUSAL 878 00:31:33,990 --> 00:31:36,626 DEPRESSION GROUP, AND WHO SHOWED 879 00:31:36,626 --> 00:31:39,162 THE PHENOTYPE OF A RECURRENCE OF 880 00:31:39,162 --> 00:31:41,064 THEIR MOOD SYMPTOMS DURING 881 00:31:41,064 --> 00:31:41,832 ESTROGEN WITHDRAWAL. 882 00:31:41,832 --> 00:31:44,000 NOW THE FIRST QUESTION WAS TO 883 00:31:44,000 --> 00:31:47,337 SEE SARAH DID PATIENT DERIVED 884 00:31:47,337 --> 00:31:50,640 LYMPHBLASTOID CELL LINES THAT 885 00:31:50,640 --> 00:31:51,441 ARE EPSTEIN BARR-INFECKED AND 886 00:31:51,441 --> 00:31:53,643 THEY ARE KIND OF OLD LYMPHOCYTES 887 00:31:53,643 --> 00:31:56,546 TO THE A LOT OF THE INITIAL 888 00:31:56,546 --> 00:31:57,714 METHYLATION MARKS AND MARKERS 889 00:31:57,714 --> 00:32:02,219 RELATED TO ENVIRONMENT OR OTHER 890 00:32:02,219 --> 00:32:03,320 FACTORS ARE WASHED OUT AND 891 00:32:03,320 --> 00:32:05,822 THERE'S JUST LEFT THE GENETIC 892 00:32:05,822 --> 00:32:08,892 CONSTITUENTS AND WE WANTED TO 893 00:32:08,892 --> 00:32:10,293 SEE WHETHER THESE CELLS ACTUALLY 894 00:32:10,293 --> 00:32:13,263 HAD THE MACHINERY TO COMMUNICATE 895 00:32:13,263 --> 00:32:15,699 WITH SEX STEROIDS SO WE 896 00:32:15,699 --> 00:32:17,267 DID--SARAH SHOWED THAT 897 00:32:17,267 --> 00:32:19,603 THESE--MOST OF THE SEX STEROID 898 00:32:19,603 --> 00:32:20,804 RECEPTORS WERE PRESENT BOTH IN 899 00:32:20,804 --> 00:32:23,039 MESSAGE AND IN PROTEIN. 900 00:32:23,039 --> 00:32:24,908 SO, THEN WHAT WHEY DID IS SHE 901 00:32:24,908 --> 00:32:27,210 SET UP EACH CELL LINE, WOULD BE 902 00:32:27,210 --> 00:32:33,150 EXPOSED TO A VEHICLE, I THINK 903 00:32:33,150 --> 00:32:35,152 JUST AS THE CONTROL ESTRADIOL 904 00:32:35,152 --> 00:32:42,826 EXPOSURE IN THE CELL SCULTURE OR 905 00:32:42,826 --> 00:32:43,727 ESTRA-DIAL EXPOSURE FOLLOWED BY 906 00:32:43,727 --> 00:32:46,630 CHANGE TO VEHICLE WHICH WOULD BE 907 00:32:46,630 --> 00:32:47,664 THE ESTRADIOL CONTROL GROUP ASK 908 00:32:47,664 --> 00:32:50,300 WE DID THAT WITH BOTH THE 909 00:32:50,300 --> 00:32:53,503 CONTROLS AS WELL ASLET 910 00:32:53,503 --> 00:32:53,970 PERIMENOPAUSAL GROUP. 911 00:32:53,970 --> 00:32:56,907 AND THEN WE HAD A SMALL COHORT 912 00:32:56,907 --> 00:32:59,910 WHICH WAS RECRUITED ABOUT YOU 913 00:32:59,910 --> 00:33:03,013 HAD A PHENOTYPE, SHE PERFORMED 914 00:33:03,013 --> 00:33:04,181 WHOLE TRANSCRIPTOME SEQUENCING 915 00:33:04,181 --> 00:33:05,982 AS WELL AS DIFFERENTIAL GENE 916 00:33:05,982 --> 00:33:08,752 EXPRESSION AND A PATHWAY NETWORK 917 00:33:08,752 --> 00:33:09,019 ANALYSIS. 918 00:33:09,019 --> 00:33:10,887 IN THE SECOND COHORT WHICH WAS A 919 00:33:10,887 --> 00:33:12,489 BROADER COHORT I THINK OF 18 920 00:33:12,489 --> 00:33:15,058 WOMEN WHO MET CRITERIA FOR 921 00:33:15,058 --> 00:33:15,659 MENOPAUSAL DEPRESSION AND 21 922 00:33:15,659 --> 00:33:18,128 CONTROLS WHO DID FOCUS ON THE 923 00:33:18,128 --> 00:33:18,929 HAVE PERIMENOPAUSAL DEPRESSION, 924 00:33:18,929 --> 00:33:21,665 SHE USED A DIFFERENT TECHNIQUE 925 00:33:21,665 --> 00:33:25,969 TO CONFIRM THE GENE EXPRESSION 926 00:33:25,969 --> 00:33:26,903 IN THAT GROUP. 927 00:33:26,903 --> 00:33:29,339 SO 2 GENES APPEAR THAD WERE OF 928 00:33:29,339 --> 00:33:30,707 BIOLOGICAL INTEREST THAT WERE 929 00:33:30,707 --> 00:33:34,110 ALSO KIND OF SEX STEROID 930 00:33:34,110 --> 00:33:34,811 RELATED, WERE SIGNIFICANT, 931 00:33:34,811 --> 00:33:35,645 DIFFERENT BETWEEN CONTROLS AND 932 00:33:35,645 --> 00:33:37,481 PATIENTS AND THAT HAD SOME 933 00:33:37,481 --> 00:33:42,185 POETIC TEBTIAL RELEVANCE FOR 934 00:33:42,185 --> 00:33:43,253 AFFECTIVE SYNDROMES. 935 00:33:43,253 --> 00:33:46,590 ONE OF THEM IS CXCL 10 WHICH IS 936 00:33:46,590 --> 00:33:48,225 A CHEMOKINE. 937 00:33:48,225 --> 00:33:49,159 PROINFLMATORY. 938 00:33:49,159 --> 00:33:52,329 IT'S ALSO CALLED IP 10, AND 939 00:33:52,329 --> 00:33:54,431 WHAT'S INTERESTING GIVEN OUR 940 00:33:54,431 --> 00:33:56,900 KIND OF EPIDEMIOLOGIC STUDIES 941 00:33:56,900 --> 00:33:57,934 THAT DISASSOCIATION BETWEEN 942 00:33:57,934 --> 00:34:00,604 HEART DEC AND DEPRESSION DURING 943 00:34:00,604 --> 00:34:02,138 PERIAND POST MENOPAUSE THAT IT 944 00:34:02,138 --> 00:34:04,975 HAS BEEN IDENTIFIED BY THE 945 00:34:04,975 --> 00:34:07,911 CLINICAL BIOMARKER FOR HEART 946 00:34:07,911 --> 00:34:09,746 FAILURE AND LEFT VENTRICULAR 947 00:34:09,746 --> 00:34:10,046 DYSFUNCTION. 948 00:34:10,046 --> 00:34:12,883 AGAIN IT IS POTENTIALLY OF 949 00:34:12,883 --> 00:34:13,884 INTEREST GIIVE THIS 950 00:34:13,884 --> 00:34:17,787 EPIDEMIOLOGIC FINDINGS OF THE 951 00:34:17,787 --> 00:34:19,689 INCREASED CARDIAC MORTALITY IN 952 00:34:19,689 --> 00:34:21,725 PERIMENOPAUSAL DEPRESSION EMPLOY 953 00:34:21,725 --> 00:34:25,896 SO WHAT SARAH FOUND IS THE HOT 954 00:34:25,896 --> 00:34:27,664 OR WHY-AXIS OF THESE KILOBASE, I 955 00:34:27,664 --> 00:34:28,765 CAN'T REMEMBER THE M BUT IF YOU 956 00:34:28,765 --> 00:34:31,668 NEED TO KNOW I CAN ASK SARAH, 957 00:34:31,668 --> 00:34:34,304 THAT SHE FOUND THAT YOU KNOW A 958 00:34:34,304 --> 00:34:35,572 HIGHER EXPRESSION IS ASSOCIATED 959 00:34:35,572 --> 00:34:37,407 WITH THE HIGHER VALUEOT Y-AXIS, 960 00:34:37,407 --> 00:34:39,809 AND THESE ARE THE CONTROL 961 00:34:39,809 --> 00:34:41,011 VALUES, DURING THE 3 HORMONE 962 00:34:41,011 --> 00:34:43,179 CONDITIONS AND THESE ARE THE 963 00:34:43,179 --> 00:34:45,649 VALUES FOR THE WOMEN WITH 964 00:34:45,649 --> 00:34:46,583 PERIMENOPAUSAL DEPRESSION AND 965 00:34:46,583 --> 00:34:49,586 YOU SEE DURING THE ESTRADIOL 966 00:34:49,586 --> 00:34:50,320 WITHDRAWAL PHASE, THIS HISTOGRAM 967 00:34:50,320 --> 00:34:51,955 HERE THAT THERE WAS A 968 00:34:51,955 --> 00:34:53,189 SIGNIFICANT INCREASE IN THE 969 00:34:53,189 --> 00:34:55,959 EXPRESSION FOR THE YEEN FOR CXCL 970 00:34:55,959 --> 00:34:56,192 10. 971 00:34:56,192 --> 00:34:59,396 SHE THEN USED IN THE SECOND 972 00:34:59,396 --> 00:35:01,932 COHORT, A LARGER COHORT WITH A 973 00:35:01,932 --> 00:35:03,600 BROADER FEIGNY TYPE, SHE USED PC 974 00:35:03,600 --> 00:35:06,903 R TO CONFIRM THE INCREASED 975 00:35:06,903 --> 00:35:07,871 EXPRESSION OF CXCL 10 AND SHE 976 00:35:07,871 --> 00:35:09,506 ALSO LOOKED TO SEA WHETHER THERE 977 00:35:09,506 --> 00:35:13,510 WAS AN INCREASED EXPRESSION IN 978 00:35:13,510 --> 00:35:16,646 THE CXCL 10 PROTEIN USING AN 979 00:35:16,646 --> 00:35:18,815 ELIZA ASSAY WHICH SHOWED IN THE 980 00:35:18,815 --> 00:35:20,584 MEDIA OF THESE CELLS, NOT IN THE 981 00:35:20,584 --> 00:35:22,819 CONTROLS BUT IN THE PATES, THERE 982 00:35:22,819 --> 00:35:23,653 WAS INCREASED EXPRESSION OF THE 983 00:35:23,653 --> 00:35:25,155 PROTEIN EMPLOY SO THAT'S 984 00:35:25,155 --> 00:35:26,990 SOMETHING WE'RE GOING TO LOOK 985 00:35:26,990 --> 00:35:29,993 FURRINGER IN OUR STUDY IN OUR 986 00:35:29,993 --> 00:35:30,627 LONGITUDINAL STUDY, THE SECOND 987 00:35:30,627 --> 00:35:35,031 YEEN WAS A YEEN THAT ENCODES THE 988 00:35:35,031 --> 00:35:37,601 CYTOCHROME P457 B 1 STEROID 989 00:35:37,601 --> 00:35:38,335 METABOLIC HORMONE, ACTUALLY 990 00:35:38,335 --> 00:35:41,638 INVOLVED IN THE METABOLISM OF 991 00:35:41,638 --> 00:35:43,640 PREGMEANA LEAN AND DATA, IT'S 992 00:35:43,640 --> 00:35:45,842 THE MAJOR ROOT FOR THE EXCRETION 993 00:35:45,842 --> 00:35:47,811 OF THESE 2 HORMONES BOTH OF 994 00:35:47,811 --> 00:35:50,680 WHICH ARE MIEWR O STEROIDS AND 995 00:35:50,680 --> 00:35:53,783 IT IS INTERESTING THAT 7 HYDROXY 996 00:35:53,783 --> 00:35:55,552 EHDA IS A BETA AGONIST SO THE 997 00:35:55,552 --> 00:35:59,923 INCREASE IN THAT COULD REFLECT 998 00:35:59,923 --> 00:36:01,191 SOME TYPE OF HOMEOSTATIC 999 00:36:01,191 --> 00:36:03,326 MECHANISM IN WOMEN WITH 1000 00:36:03,326 --> 00:36:03,994 PERIMENOPAUSAL DEPRESSION EMPLOY 1001 00:36:03,994 --> 00:36:08,398 WHAT WE FOUND HERE AGAIN, 1002 00:36:08,398 --> 00:36:09,366 SIMILAR CONSTRUCT TO THE SLIDE, 1003 00:36:09,366 --> 00:36:12,702 IN THE WOMEN WITH PERIMENOPAUSAL 1004 00:36:12,702 --> 00:36:13,903 DEPRESSION ACROSS ALL 3 HORMONE 1005 00:36:13,903 --> 00:36:16,439 CONDITIONS SO THIS IS MORE OF A 1006 00:36:16,439 --> 00:36:19,175 STRAIGHT MARKER RATHER THAN 1007 00:36:19,175 --> 00:36:20,677 SOMETHING RELATED TO ESTROGEN 1008 00:36:20,677 --> 00:36:22,178 WITHDRAWAL THAT THERE WAS AN 1009 00:36:22,178 --> 00:36:23,913 INCREASED EXPRESSION OF THIS 1010 00:36:23,913 --> 00:36:24,381 GENE. 1011 00:36:24,381 --> 00:36:27,017 THAT WAS CONFIRMED IN THE 1012 00:36:27,017 --> 00:36:28,752 BROADER PHENOTYPE BY PC R, AND 1013 00:36:28,752 --> 00:36:31,454 THAT ALSO WHEN WE TOOK--ADD THE 1014 00:36:31,454 --> 00:36:32,822 HORMONE LEVELS FOR THE WOMEN 1015 00:36:32,822 --> 00:36:34,124 THAT PARTICIPATE INDEED THIS 1016 00:36:34,124 --> 00:36:36,726 STUDY, IN THE LARGER PHENOTYPE, 1017 00:36:36,726 --> 00:36:39,429 THAT THE EXPRESSION OF THIS GENE 1018 00:36:39,429 --> 00:36:43,633 CORRELATED WITH DHEA LEVELS IN 1019 00:36:43,633 --> 00:36:44,401 THOSE WOMEN. 1020 00:36:44,401 --> 00:36:47,871 SO AGAIN IT'S GOT BIOLOGICAL 1021 00:36:47,871 --> 00:36:51,675 RELEVANCE AND WE HOPE TO BE 1022 00:36:51,675 --> 00:36:54,310 LOOKING AT IN CONSTANTS THE 1023 00:36:54,310 --> 00:36:55,145 LONGITUDINAL STUDY, BOTH THE 1024 00:36:55,145 --> 00:36:58,448 CHANGE IN THESE INFLAMMATORY 1025 00:36:58,448 --> 00:37:00,183 MARKERSA WELL AS THESE HORMONES 1026 00:37:00,183 --> 00:37:03,553 THAT MIGHT BE ALTERED BY AN 1027 00:37:03,553 --> 00:37:05,321 ALERATION IN THE SIP 7 B1. 1028 00:37:05,321 --> 00:37:10,860 SO IN SUMMARY THEN, THESE DATA 1029 00:37:10,860 --> 00:37:13,763 SUGGEST THAT INCREASED CXCL10 1030 00:37:13,763 --> 00:37:18,168 BEING BE A RISK FACTOR FOR BOTH 1031 00:37:18,168 --> 00:37:19,969 PERIMENOPAUSAL DEPRESSION AND 1032 00:37:19,969 --> 00:37:21,705 CARDIOVASCULAR DISEASE 1033 00:37:21,705 --> 00:37:24,774 CONSISTENT WITH JENNIFER 1034 00:37:24,774 --> 00:37:27,343 GLORDON'S WORK SHOWING THAT IT 1035 00:37:27,343 --> 00:37:28,178 PREVENTED PERIMENOPAUSAL 1036 00:37:28,178 --> 00:37:29,512 DEPRESSION AND PREVENTED HEART 1037 00:37:29,512 --> 00:37:31,114 DISEASE ALTHOUGH THIS IS 1038 00:37:31,114 --> 00:37:31,848 CONTROVERSIAL. 1039 00:37:31,848 --> 00:37:35,318 IT ALSO COULD SUGGIEST THAT THE 1040 00:37:35,318 --> 00:37:36,853 BENEFITS OF ESTRADIOL THERAPY 1041 00:37:36,853 --> 00:37:38,655 FOR DEPRESSION AND 1042 00:37:38,655 --> 00:37:39,389 CARDIOVASCULAR INDICATIONS IN 1043 00:37:39,389 --> 00:37:41,891 SOME WOMEN, AGAIN THIS, IS A 1044 00:37:41,891 --> 00:37:45,195 SUBGROUP OF WOMEN, THE MAJORITY 1045 00:37:45,195 --> 00:37:47,497 OF WOMEN GO THROUGH 1046 00:37:47,497 --> 00:37:48,331 PERIMENOPAUSE WITHOUT ANY 1047 00:37:48,331 --> 00:37:51,267 EPISODES OF DEPRESSION BUT IT 1048 00:37:51,267 --> 00:37:53,470 COULD SERVE AS 1 POTENTIAL 1049 00:37:53,470 --> 00:37:55,004 EXPLANATION ALTHOUGH THERE ARE 1050 00:37:55,004 --> 00:37:57,140 MANY FOR THE DISCORDANT 1051 00:37:57,140 --> 00:37:58,074 RESULTINGS FOR OBSERVATIONAL 1052 00:37:58,074 --> 00:37:59,609 STUDIES LOOKINGA THE HORMONE 1053 00:37:59,609 --> 00:38:01,077 EFFECTS OF THERAPY IN WOMEN AND 1054 00:38:01,077 --> 00:38:03,113 NEGATIVE FINDINGS OF THE 1055 00:38:03,113 --> 00:38:04,380 WEMENT'S HEALTH INITIATIVE. 1056 00:38:04,380 --> 00:38:06,216 FINALLY IT SUGGESTS THAT THE 1057 00:38:06,216 --> 00:38:08,318 ROLE OF NEUROSTEROIDS IN 1058 00:38:08,318 --> 00:38:09,085 PERIMENOPAUSAL DEPRESSION AND 1059 00:38:09,085 --> 00:38:10,887 THERE IS 1 TRIAL ONGOING DOWN AT 1060 00:38:10,887 --> 00:38:13,423 THE UNIVERSITY OF SOUTHWEST IN 1061 00:38:13,423 --> 00:38:18,695 TEXAS LOOKINGA THE EFFECTS OF 1062 00:38:18,695 --> 00:38:20,029 PREGNENOLONE AS A TREME FOR 1063 00:38:20,029 --> 00:38:20,430 THESE WOMEN. 1064 00:38:20,430 --> 00:38:22,031 IF I HAVE A FEW MINUTES WHICH I 1065 00:38:22,031 --> 00:38:27,070 DO, I WANT TO GO THROUGH 1066 00:38:27,070 --> 00:38:29,672 PRELIMINARY OTHERWISE LESS 1067 00:38:29,672 --> 00:38:31,174 VETTED MATERIAL THAT 1068 00:38:31,174 --> 00:38:32,876 DR. [INDISCERNIBLE] HAS FOUND 1069 00:38:32,876 --> 00:38:33,143 RECENTLY. 1070 00:38:33,143 --> 00:38:36,346 AND WHAT SHE DID WAS EMPLOY A 1071 00:38:36,346 --> 00:38:38,214 DATA-DRIVEN APPROACH RATHER THAN 1072 00:38:38,214 --> 00:38:40,750 LITERATURE BASED ON APPROACH TO 1073 00:38:40,750 --> 00:38:43,052 LOOKING AT KIND OF GENE NETWORKS 1074 00:38:43,052 --> 00:38:46,089 AND HUB YEENS THAT MAY ALSO BE 1075 00:38:46,089 --> 00:38:46,990 RELEVANT IN PERIMENOPAUSAL 1076 00:38:46,990 --> 00:38:49,359 DEPRESSION AND THIS IS A CLUSTER 1077 00:38:49,359 --> 00:38:51,561 DENDRITIC CELL ROUGH ATOM GRAM 1078 00:38:51,561 --> 00:38:52,529 WHICH SHOWS DRVESS IN GENE 1079 00:38:52,529 --> 00:38:53,930 EXPRESSION THAT ARE HIGHLY 1080 00:38:53,930 --> 00:39:00,170 CORRELATED WITH EACH OTHER, AND 1081 00:39:00,170 --> 00:39:03,740 THEY THEN DEFINE THESE CLUSTERS 1082 00:39:03,740 --> 00:39:05,208 OF OTHERWISE CORRELATED GENES 1083 00:39:05,208 --> 00:39:07,710 AND WE'LL FIND IN THE MOST 1084 00:39:07,710 --> 00:39:09,345 HEAVILY CORRELATED GENE HUB OR A 1085 00:39:09,345 --> 00:39:11,047 HUB FOR THAT CLUSTER. 1086 00:39:11,047 --> 00:39:12,582 AND THEN THESE ARE THEN 1087 00:39:12,582 --> 00:39:15,351 PROCESSED WITH RESPECT TO THEIR 1088 00:39:15,351 --> 00:39:20,623 CORRELATIONS IN A VERY LARGE 1089 00:39:20,623 --> 00:39:21,524 MATRIX, MULTIPLE MATRIXES 1090 00:39:21,524 --> 00:39:23,092 SIMILAR TO WHAT'S BEEN DONE IN 1091 00:39:23,092 --> 00:39:25,295 THE BRAIN IMAGING STUDIES WITH 1092 00:39:25,295 --> 00:39:26,462 RESTINGITATE TO IDENTIFY 1093 00:39:26,462 --> 00:39:28,031 DIFFERENCES EITHER BETWEEN 1094 00:39:28,031 --> 00:39:30,767 PATIENTS AND CONTROLS OR BETWEEN 1095 00:39:30,767 --> 00:39:32,802 KIND OF ESTRO GENERATED 1096 00:39:32,802 --> 00:39:34,504 WITHDRAWAL AND ESTRO GENERATED 1097 00:39:34,504 --> 00:39:35,705 THERAPY AND THEN THOSE DEFENSES 1098 00:39:35,705 --> 00:39:37,240 ARE MAPPED ON TO BASED ON 1099 00:39:37,240 --> 00:39:39,309 LITERATURE OF KIND OF AREAS OF 1100 00:39:39,309 --> 00:39:40,343 GENE EXPRESSION THAT ARE 1101 00:39:40,343 --> 00:39:42,812 RELEVANT FOR A VARIETY OF 1102 00:39:42,812 --> 00:39:44,113 BIOLOGICAL PROCESSES, AND WHAT 1103 00:39:44,113 --> 00:39:46,282 SARAH HAS DONE THEN WITH THIS 1104 00:39:46,282 --> 00:39:50,019 DATA DRIVEN APPROACH IS 1105 00:39:50,019 --> 00:39:51,721 IDENTIFIED SEVERAL MODULES THAT 1106 00:39:51,721 --> 00:39:54,490 ARE RELEVANT FOR EITHER ESTROGEN 1107 00:39:54,490 --> 00:39:55,959 WITHDRAWAL OR FOR PERIMENOPAUSAL 1108 00:39:55,959 --> 00:39:57,660 DEPRESSION AND 1 OF THEM IS 1109 00:39:57,660 --> 00:40:00,163 RELATED TO THIS MIDNIGHT BLUE 1110 00:40:00,163 --> 00:40:02,298 MODULE WHICH IS WHEN WE LOOK AT 1111 00:40:02,298 --> 00:40:06,870 IT, IS 1 OF THE HUB GENES IS THE 1112 00:40:06,870 --> 00:40:08,738 PER 1 GENE WHICH MANY OF YOU 1113 00:40:08,738 --> 00:40:13,309 KNOW IS VERY RELEVANT FOR 1114 00:40:13,309 --> 00:40:14,210 GENERATING CIRCADIAN RHYTHMS, IT 1115 00:40:14,210 --> 00:40:18,381 MAY SPEAK TO SOME OF THE SLEEP 1116 00:40:18,381 --> 00:40:19,949 ISSUES THAT ARE PRESENT AND HAVE 1117 00:40:19,949 --> 00:40:21,584 BEEN IDENTIFIED DURING THE 1118 00:40:21,584 --> 00:40:26,022 PERIMENOPAUSE OR IN THE CONTEXT 1119 00:40:26,022 --> 00:40:26,723 OF PERIMENOPAUSAL DEPRESSION AND 1120 00:40:26,723 --> 00:40:29,259 ALSO MAY HELP US GIVE US A CLUE 1121 00:40:29,259 --> 00:40:31,127 AS TO WHAT MIGHT BE UNDERLYING 1122 00:40:31,127 --> 00:40:33,563 SOME OF THESE OR PUT AT A RISK 1123 00:40:33,563 --> 00:40:37,100 FACTOR FOR SOME OF THESE 1124 00:40:37,100 --> 00:40:37,500 CONDITIONS. 1125 00:40:37,500 --> 00:40:40,036 A SECOND GENE IS IN THIS OTHER 1126 00:40:40,036 --> 00:40:41,971 MODULE, THE DARK ORANGE WHICH 1127 00:40:41,971 --> 00:40:45,008 CONTAINS THE HUB GENE FOR 1128 00:40:45,008 --> 00:40:46,175 CXCL10, THE CYTOKINE I TALKED 1129 00:40:46,175 --> 00:40:48,044 ABOUT THAT SHE HAD IDENTIFIED 1130 00:40:48,044 --> 00:40:50,346 EARLIER BUT ALSO WHEN SARAH 1131 00:40:50,346 --> 00:40:52,215 COMPARED THIS WITH THE UK 1132 00:40:52,215 --> 00:40:55,485 BIOBANK THAT IT KIND OF 1133 00:40:55,485 --> 00:40:56,653 OVERLAPPED WITH WITH STUDIES IN 1134 00:40:56,653 --> 00:41:00,323 WOMEN WITH AN EARLIER AGENT OF 1135 00:41:00,323 --> 00:41:02,859 MENOPAUSE AND I KNOW THIS' A 1136 00:41:02,859 --> 00:41:04,260 CURRENT STUDY, HOWARD LEE IS 1137 00:41:04,260 --> 00:41:09,032 LOOKING AT THIS DATA IN WOMEN 1138 00:41:09,032 --> 00:41:10,934 WITH PREMATURE OVARIAN 1139 00:41:10,934 --> 00:41:13,069 INSUFFICIENCY, THERE HAS BEEN IN 1140 00:41:13,069 --> 00:41:14,904 THE LITERATURE ON PERIMENOPAUSAL 1141 00:41:14,904 --> 00:41:15,872 DEPRESSION, A LINK BETWEEN 1142 00:41:15,872 --> 00:41:17,874 PERHAPS AN EARLIER AGE OF 1143 00:41:17,874 --> 00:41:20,944 MENOPAUSE AND THE ONSET OF 1144 00:41:20,944 --> 00:41:21,244 DEPRESSION. 1145 00:41:21,244 --> 00:41:23,146 I ALWAYS INTERPRET IT AS A 1146 00:41:23,146 --> 00:41:24,781 POTENTIAL, THE EFFECTS OF STRESS 1147 00:41:24,781 --> 00:41:27,150 AND DEPRESSION THAT LED TO AN 1148 00:41:27,150 --> 00:41:29,585 EARLIER LOSS OF OVARIAN FUNCTION 1149 00:41:29,585 --> 00:41:31,054 BUT THIS DATA WE WOULD HAVE TO 1150 00:41:31,054 --> 00:41:32,121 KRE TINS CONSIDER THAT OR I 1151 00:41:32,121 --> 00:41:33,957 WOULD HAVE TO KRE TINS OCCUR 1152 00:41:33,957 --> 00:41:36,726 THAT AND IT MAY ACTUALLY BE AN 1153 00:41:36,726 --> 00:41:38,494 UNDERLYING RISK FOR BOTH 1154 00:41:38,494 --> 00:41:39,662 PERIMENOPAUSAL DEPRESSION AND AN 1155 00:41:39,662 --> 00:41:41,864 EARLIER ONSET OF THE MENOPAUSE 1156 00:41:41,864 --> 00:41:44,734 IN SOME WOMEN EMPLOY SO, OVERALL 1157 00:41:44,734 --> 00:41:53,009 THEN TO END, WE ARE WORKING ON 1158 00:41:53,009 --> 00:41:56,179 THIS TYPE OF STUDY DESIGNS AND 1159 00:41:56,179 --> 00:41:57,814 TO BETTER UNDERSTAND THE EFFORT 1160 00:41:57,814 --> 00:42:03,419 OF THESE BIOLOGY CONDITIONS DITD 1161 00:42:03,419 --> 00:42:04,587 UNDERSTANDING WHY IN SOME WOMEN 1162 00:42:04,587 --> 00:42:09,892 THIS SEEMS TO BE A NORMAL CHANGE 1163 00:42:09,892 --> 00:42:10,960 OF OVARIAN FUNCTION CAN TRIGGER 1164 00:42:10,960 --> 00:42:12,362 THIS MOOD STATE AND HOPEFULLY 1165 00:42:12,362 --> 00:42:13,930 THAT WILL DEVELOP NEW TREATMENTS 1166 00:42:13,930 --> 00:42:16,432 AND HAVE A DIFFERENT MORE 1167 00:42:16,432 --> 00:42:17,867 FOCUSED TARGET AND A DIFFERENT 1168 00:42:17,867 --> 00:42:19,936 SAFETY PROFILE IN ALL OF THESE 1169 00:42:19,936 --> 00:42:22,372 CONDITIONS AND HOPEFULLY SOME OF 1170 00:42:22,372 --> 00:42:24,207 OUR INVITRO STUDIES WILL 1171 00:42:24,207 --> 00:42:26,376 IDENTIFY MARKERS OF RISK OR 1172 00:42:26,376 --> 00:42:26,909 POTENTIALLY LEAD TO SOME 1173 00:42:26,909 --> 00:42:31,147 TREATMENTS THAT MAY BE MORE 1174 00:42:31,147 --> 00:42:33,850 NOVEL AND ALTERNATIVE AT LEAST 1175 00:42:33,850 --> 00:42:35,651 FOR WOMEN WITH THIS STANDARD 1176 00:42:35,651 --> 00:42:36,452 HORMONE THERAPY EMPLOY WITH THAT 1177 00:42:36,452 --> 00:42:39,122 IN MIND I WANT TO ACKNOWLEDGE 1178 00:42:39,122 --> 00:42:41,491 PEOPLE IN MY GROUP, SARAH 1179 00:42:41,491 --> 00:42:42,992 SPECTER, THE NURSE PRACTITIONER 1180 00:42:42,992 --> 00:42:44,927 IN THE GROUP, [INDISCERNIBLE] 1181 00:42:44,927 --> 00:42:48,364 WHO IS MORE FOCUSED ON OUR 1182 00:42:48,364 --> 00:42:49,499 PREMENSTRUAL DYSPHORIC STUDIES 1183 00:42:49,499 --> 00:42:52,235 BUT RUNS OUR LARGE CUMBERSOME 1184 00:42:52,235 --> 00:42:56,773 AND BEAR LIKE PUBERTY STUDY. 1185 00:42:56,773 --> 00:42:59,275 SARAH RUDZINSKAS, I MENTIONED, 1186 00:42:59,275 --> 00:43:06,382 AS WELL AS CONSTRANS ZAU, I WANT 1187 00:43:06,382 --> 00:43:08,885 TO MENTION PAUL WAKIM, WHILE HE 1188 00:43:08,885 --> 00:43:12,722 WAS HERE AND NOW XIAOBAI, LI, 1189 00:43:12,722 --> 00:43:14,724 WHO IS NOW FITTING US IN WITH 1190 00:43:14,724 --> 00:43:17,560 THEIR NORMAL DUTIES TO BE 1191 00:43:17,560 --> 00:43:18,194 STATISTICAL CONSULTANTS. 1192 00:43:18,194 --> 00:43:24,600 FINALLY SOME OF MY LONGEST 1193 00:43:24,600 --> 00:43:25,868 STANDING COLLABORATORS, KAREN 1194 00:43:25,868 --> 00:43:31,908 BERM AN AT NIH, LINNET NEEMAN 1195 00:43:31,908 --> 00:43:33,676 WHO HAS BEEN INVOLVED IN THESE 1196 00:43:33,676 --> 00:43:35,511 STUDIES, DAVID CANNED WHAT AT 1197 00:43:35,511 --> 00:43:40,216 UNC AND THEN DAVID GOLDMAN 1198 00:43:40,216 --> 00:43:41,384 RUNNING OUR COLLABORATION WITH 1199 00:43:41,384 --> 00:43:44,654 OUR MOLECULAR STUDIES SO WITH 1200 00:43:44,654 --> 00:43:54,030 THAT WE CAN, ALL 10 OF YOU CAN 1201 00:43:54,030 --> 00:43:54,230 CLAP. 1202 00:43:54,230 --> 00:44:01,804 [ APPLAUSE ] 1203 00:44:01,804 --> 00:44:04,340 NHI, I'M [INDISCERNIBLE] I'M A 1204 00:44:04,340 --> 00:44:07,677 NEW CLINICAL FELLOW FOR CARLOS 1205 00:44:07,677 --> 00:44:09,045 [INDISCERNIBLE], WE'RE STUDYING 1206 00:44:09,045 --> 00:44:10,480 RESISTANCE TO DEPRESSION AND 1207 00:44:10,480 --> 00:44:11,981 BIOMARKERS SO FAR HAVE BEEN 1208 00:44:11,981 --> 00:44:14,617 FOCUSED ON THE GLUTAMATE SYSTEM, 1209 00:44:14,617 --> 00:44:16,152 MY PROJECT IN THAT LAB, WE'RE 1210 00:44:16,152 --> 00:44:19,222 BEGINNING TO ELECTRIC AT 1211 00:44:19,222 --> 00:44:21,190 NEUROSTEROIDS AND MYSELF, VERY 1212 00:44:21,190 --> 00:44:24,127 INTERESTED IN NEUROPEPTIDE 1213 00:44:24,127 --> 00:44:25,161 SPECIFICALLY, VASE O SUPPRESS 1214 00:44:25,161 --> 00:44:26,129 EVALUATION PROCESS AND OXYTOCIN, 1215 00:44:26,129 --> 00:44:27,897 AND FROM THE LITERATURE REVIEW, 1216 00:44:27,897 --> 00:44:31,801 I'VE DONE SO FAR, IT SEEMS LIKE, 1217 00:44:31,801 --> 00:44:33,269 WELLOXYITOSEIN IS HARD TO 1218 00:44:33,269 --> 00:44:37,440 MEASURE AND ALSO KIND OF HARD TO 1219 00:44:37,440 --> 00:44:37,640 GIVE. 1220 00:44:37,640 --> 00:44:40,276 VASE O PRESS ANT IS VERY RELATED 1221 00:44:40,276 --> 00:44:46,549 TOOXYITOSEIN BUT LOOKING AT 1222 00:44:46,549 --> 00:44:48,484 THAT, AS AOXYITOSEIN AND 1223 00:44:48,484 --> 00:44:52,021 [INDISCERNIBLE] AS A YING AND 1224 00:44:52,021 --> 00:44:53,489 YANG SYSTEM, AND MY 1225 00:44:53,489 --> 00:44:54,891 UNDERSTANDING IS THERE'S A LOT 1226 00:44:54,891 --> 00:44:57,894 OF SEX DNCHS IN HOW IT AFFECTS 1227 00:44:57,894 --> 00:44:58,628 DEPRSESSIVE SYMPTOMS AMONG 1228 00:44:58,628 --> 00:45:02,064 OTHERS AND I'M WONDERING, DO YOU 1229 00:45:02,064 --> 00:45:03,566 HAVE ANY SUGGESTIONS ON LOOKING 1230 00:45:03,566 --> 00:45:05,168 AT THE INTERSECTION OF 1231 00:45:05,168 --> 00:45:06,269 NEUROSTERIES LIKE YOU'VE DONE 1232 00:45:06,269 --> 00:45:10,139 AND NEUROPEPTIDES AND IF YOU 1233 00:45:10,139 --> 00:45:11,174 HAVE ANY WHYEDS? 1234 00:45:11,174 --> 00:45:12,341 NYEAH, VERY GOOD QUESTION. 1235 00:45:12,341 --> 00:45:17,113 INTERESTING THAT YOU'RE WORKING 1236 00:45:17,113 --> 00:45:17,747 ON THAT. 1237 00:45:17,747 --> 00:45:20,383 YES, SO THERE ARE SEVERAL WELL 1238 00:45:20,383 --> 00:45:21,450 DOCUMMED SEX DIFFERENCES BOTH IN 1239 00:45:21,450 --> 00:45:23,986 TERMS OF THE WIRING AND THE IRPT 1240 00:45:23,986 --> 00:45:26,322 ACTIONS OF KIND OF NEUROSTEROIDS 1241 00:45:26,322 --> 00:45:30,626 AND PEPTIDES, WHEN I STAY 1242 00:45:30,626 --> 00:45:32,428 NEUROSTEROIDS, I SAY ESTROGEN IS 1243 00:45:32,428 --> 00:45:33,329 NEUROACTIVE AND MAY ACTUALLY BE 1244 00:45:33,329 --> 00:45:38,668 MADE IN THE BRAIN JUST LIKE, THE 1245 00:45:38,668 --> 00:45:42,738 CLASSIC NEUROSTEROIDS THAT PAUL 1246 00:45:42,738 --> 00:45:44,040 [INDISCERNIBLE] DESCRIBED AS 1247 00:45:44,040 --> 00:45:44,774 METABOLITES OF PROGESTERONE IN 1248 00:45:44,774 --> 00:45:47,009 THE BRAIN OR AT LATEST ALL THE 1249 00:45:47,009 --> 00:45:48,244 SYNTHETIC ENZYMES ARE REQUIRED 1250 00:45:48,244 --> 00:45:49,345 AND PRESENT AND HAVE BEEN 1251 00:45:49,345 --> 00:45:50,413 IDENTIFIED IN THE BRAIN AND 1252 00:45:50,413 --> 00:45:56,919 CERTAIN LYE, I THINK IN MANY OF 1253 00:45:56,919 --> 00:45:59,855 THE SYSTEMS, PARTICULARLY IN THE 1254 00:45:59,855 --> 00:46:04,327 SOCIAL MODELS WITH THE VOLES, 1255 00:46:04,327 --> 00:46:05,962 TOM [INDISCERNIBLE]'S WORK AND 1256 00:46:05,962 --> 00:46:08,164 YOUNG'S WORK, THE WIRING OF 1257 00:46:08,164 --> 00:46:10,800 ESTRO GENRE SEPTORSORS BOTH ER 1258 00:46:10,800 --> 00:46:14,003 ALPHA AND ER BETA AS TO THE 1259 00:46:14,003 --> 00:46:16,839 REGULATION OF OXYTOCIN AND BASAL 1260 00:46:16,839 --> 00:46:22,144 DEPRESS ANT LOOK AT THE MODEL 1261 00:46:22,144 --> 00:46:24,280 FOR HOW THOSE MAY INTERACT AND 1262 00:46:24,280 --> 00:46:25,348 THE VARIABILITY THAT MAY OCCUR 1263 00:46:25,348 --> 00:46:26,482 IN THEM. 1264 00:46:26,482 --> 00:46:28,584 AS YOU SAID, THEY'RE 1265 00:46:28,584 --> 00:46:29,318 PROBLEMATIC, THEY'RE EASIER TO 1266 00:46:29,318 --> 00:46:31,687 MEASURE THAN THEY USED TO BE 20 1267 00:46:31,687 --> 00:46:32,755 YEARS AGO BUT THEIR PROBLEM WITH 1268 00:46:32,755 --> 00:46:38,527 HOW THEY GET INTO THE BRAIN, 1269 00:46:38,527 --> 00:46:39,929 WHERE THEY INTERACT, I THINK IN 1270 00:46:39,929 --> 00:46:42,431 SOME OF THE ANIMAL STUDIES, IT'S 1271 00:46:42,431 --> 00:46:45,334 CLEAR IF YOU GIVE VASO-PRESSIN 1272 00:46:45,334 --> 00:46:48,504 IN FEMALES THERE WILL BE KIND OF 1273 00:46:48,504 --> 00:46:52,908 A FRIEND AND BEFRIEND ACTION 1274 00:46:52,908 --> 00:46:55,845 WHEREAS, YOU GIVE IT TO MALES 1275 00:46:55,845 --> 00:46:57,947 THEY GET MORE DEFENSIVE AND MORE 1276 00:46:57,947 --> 00:46:59,382 TERRITORIAL. 1277 00:46:59,382 --> 00:47:00,783 SO THERE'S WONDERFUL SEXER 1278 00:47:00,783 --> 00:47:04,720 DIFFERENCES AND BEHAVIOR, AND 1279 00:47:04,720 --> 00:47:06,555 SEX DIFFERENCES IN BRAIN, IT'S 1280 00:47:06,555 --> 00:47:09,825 JUST IT'S KIND OF LIKE 1281 00:47:09,825 --> 00:47:10,760 [INDISCERNIBLE] MYTH THAT 1282 00:47:10,760 --> 00:47:12,762 THERE'S SO MANY CHOICES IT 1283 00:47:12,762 --> 00:47:14,497 STARTS GETTING VERY COMPLICATED 1284 00:47:14,497 --> 00:47:15,698 BUT WOULD BE HAPPY TO TALK WITH 1285 00:47:15,698 --> 00:47:26,142 YOU AND CARLOS ABOUT THIS. 1286 00:47:28,144 --> 00:47:29,045 >> THANK YOU DR. SCHMIDT FOR 1287 00:47:29,045 --> 00:47:30,513 SHARING YOUR WORK AND INSIGHTS 1288 00:47:30,513 --> 00:47:31,714 ON THIS VERY IMPORTANT PROBLEM. 1289 00:47:31,714 --> 00:47:33,416 WE DO HAVE A COUPLE QUESTIONS 1290 00:47:33,416 --> 00:47:36,185 THAT CAME IN FROM OUR VIDEOCAST 1291 00:47:36,185 --> 00:47:38,354 VIEWERS, 1 IS HOW DOES ANOREXIA 1292 00:47:38,354 --> 00:47:40,589 IN A TIME OF PERIMENOPAUSE 1293 00:47:40,589 --> 00:47:45,227 AFFECT THE HORMONE LEVELS IN 1294 00:47:45,227 --> 00:47:46,162 DEPRESSION? 1295 00:47:46,162 --> 00:47:47,396 >> GOOD QUESTION. 1296 00:47:47,396 --> 00:47:51,500 WHEN I WAS IN TRIAL, I WORKED A 1297 00:47:51,500 --> 00:47:53,135 FAIR AMOUNT BECAUSE THERE WAS A 1298 00:47:53,135 --> 00:47:55,571 BIG PROGRAM ON EATING DISORDERS, 1299 00:47:55,571 --> 00:47:59,742 SO I THINK THE MAIN WORK ON THAT 1300 00:47:59,742 --> 00:48:01,644 EITHER IN SAN DIEGO OR IN 1301 00:48:01,644 --> 00:48:04,580 HARVARD, I DON'T THINK ANYBODY'S 1302 00:48:04,580 --> 00:48:07,249 EVER LOOKED AT THE, WHEREVER YOU 1303 00:48:07,249 --> 00:48:09,819 ARE, SORRY, I KEEP LOOKING AT 1304 00:48:09,819 --> 00:48:09,985 YOU. 1305 00:48:09,985 --> 00:48:10,486 >> IT'S OKAY. 1306 00:48:10,486 --> 00:48:13,322 >> I DON'T KNOW IF ANYBODY'S 1307 00:48:13,322 --> 00:48:16,692 LOOKED AT WHETHER OR FOLLOWED 1308 00:48:16,692 --> 00:48:19,328 WOMEN WITH OR MEN WITH EATING 1309 00:48:19,328 --> 00:48:21,464 DISORDERS THAT IS A GO THROUGH 1310 00:48:21,464 --> 00:48:23,966 THE MENOPAUSE TRANSITION. 1311 00:48:23,966 --> 00:48:27,002 I THINK THE--YOU KNOW IT'S 1312 00:48:27,002 --> 00:48:30,072 SYRUPLY THE ENDOCRINE EFFECTS OF 1313 00:48:30,072 --> 00:48:33,676 STARVATION ARE VERY PROMINENT 1314 00:48:33,676 --> 00:48:37,780 AND CAN INDUCE AMENERRIA LIKE 1315 00:48:37,780 --> 00:48:38,814 SARAH BURGER'S WORK AND OTHER 1316 00:48:38,814 --> 00:48:40,249 VERY LONGS HAVE SHOWN THAT WHEN 1317 00:48:40,249 --> 00:48:45,087 THERE'S A CERTAIN THRESHOLD OF 1318 00:48:45,087 --> 00:48:47,957 CALORIES INTAKE BELOW WHICH THE 1319 00:48:47,957 --> 00:48:50,826 REPRODUCTIVE ACTS SHUTS DOWN, 1320 00:48:50,826 --> 00:48:52,161 IT'S CONSIDERABLY VARIABLE 1321 00:48:52,161 --> 00:48:54,130 ACROSS WOMEN BUT INN REXIO THAT 1322 00:48:54,130 --> 00:48:56,165 IS 1 OF THE GREAT COMPLICATIONS 1323 00:48:56,165 --> 00:49:03,139 AND WOMEN OR GIRLS WITH 1324 00:49:03,139 --> 00:49:03,839 ANOREXIA, THAT OFTEN PREVENT 1325 00:49:03,839 --> 00:49:05,274 THEM FROM GETTING INTO THE 1326 00:49:05,274 --> 00:49:07,176 PUBERTY EXPE 1 OF THE PROBLEMS 1327 00:49:07,176 --> 00:49:10,146 WE USED TO FACE INTRADA IS WHEN 1328 00:49:10,146 --> 00:49:11,781 THOSE GIRLS START GETTING REFED 1329 00:49:11,781 --> 00:49:13,649 AND THEIR AXIS STARTS 1330 00:49:13,649 --> 00:49:15,050 REACTIVATING THEN THEY START 1331 00:49:15,050 --> 00:49:18,621 MAKING ESTROIEN AND THEIR BONES 1332 00:49:18,621 --> 00:49:19,955 SURDENLY START CLOSING AND THEY 1333 00:49:19,955 --> 00:49:22,525 MAY BE AT REFRESHING FOR SHORT 1334 00:49:22,525 --> 00:49:24,360 STARTY STATURE SO WE WOULD HAVE 1335 00:49:24,360 --> 00:49:25,961 TO PROLONG SUPPRESSION OF 1336 00:49:25,961 --> 00:49:27,963 PUBERTY IN THEM WHILE THEY WERE 1337 00:49:27,963 --> 00:49:29,932 REFEEDING AND LET THINGS HAPPEN 1338 00:49:29,932 --> 00:49:31,100 MORE TBRADDUALLY. 1339 00:49:31,100 --> 00:49:32,468 THERE'S ALSO BEEN CANNED WHAT'S 1340 00:49:32,468 --> 00:49:34,770 GROUP UP IN HARVARD DEMON 1341 00:49:34,770 --> 00:49:38,307 TRAITED RELEVANCE OF SOME 1342 00:49:38,307 --> 00:49:38,874 ANDROGENS PARTICULARLY 1343 00:49:38,874 --> 00:49:40,042 TESTOSTERONE IN THAT GROUP. 1344 00:49:40,042 --> 00:49:42,611 TO BE HONEST I THINK A LOT OF 1345 00:49:42,611 --> 00:49:44,413 WOMEN WITH EATING DISORDERS GET 1346 00:49:44,413 --> 00:49:46,749 LOST AS THEY AGE AND I THINK 1347 00:49:46,749 --> 00:49:48,584 THAT WHAT HAPPENS, THERE USED TO 1348 00:49:48,584 --> 00:49:50,886 BE A SENSE THAT THESE THINGS 1349 00:49:50,886 --> 00:49:51,821 WOULD JUST BECOME CHRONIC AND 1350 00:49:51,821 --> 00:49:54,023 THE WOMAN IF THEY SURVIVED TO 1351 00:49:54,023 --> 00:49:57,593 THAT AIM, THEY WOULD HAVE FOUND 1352 00:49:57,593 --> 00:50:00,796 BALANCE BETWEEN THEIR EATING 1353 00:50:00,796 --> 00:50:02,998 DISORDER AND KIND OF STAYING 1354 00:50:02,998 --> 00:50:03,199 ALIVE. 1355 00:50:03,199 --> 00:50:08,037 SOIME NOT SURE WHAT HAPPENS, TO 1356 00:50:08,037 --> 00:50:09,171 BE HONEST. 1357 00:50:09,171 --> 00:50:09,472 >> GREAT. 1358 00:50:09,472 --> 00:50:10,239 THANK YOU NIT'S PROBABLY NOT 1359 00:50:10,239 --> 00:50:11,640 GOING TO HELP IF THEY STOP 1360 00:50:11,640 --> 00:50:13,843 EATING AS THEY GO THROUGH THE 1361 00:50:13,843 --> 00:50:16,145 MENOPAUSE NAS A PEDIATRIC 1362 00:50:16,145 --> 00:50:17,279 CARDIOLOGIST, I WOULD PROBABLY 1363 00:50:17,279 --> 00:50:17,913 APREWITH THAT. 1364 00:50:17,913 --> 00:50:20,082 ANOTHER QUESTION THAT CAME IN IS 1365 00:50:20,082 --> 00:50:22,184 HOW DOES SURGICAL MENOPAUSE I. 1366 00:50:22,184 --> 00:50:24,186 E. HYSTERECTOMY ALTER THE 1367 00:50:24,186 --> 00:50:25,354 INFLMATORY RESPONSE OF DECLINE 1368 00:50:25,354 --> 00:50:27,790 IN HORMONES FROM THE RAPID 1369 00:50:27,790 --> 00:50:30,326 INDUCTION COMPARED TO 1370 00:50:30,326 --> 00:50:31,694 QUOTE-UNQUOTE NORMAL BIOLOGICAL 1371 00:50:31,694 --> 00:50:33,062 PROGRESSION OVER TIME? 1372 00:50:33,062 --> 00:50:34,597 >> YES, SO, IT MIMICS WHAT A 1373 00:50:34,597 --> 00:50:36,565 WOMAN GOES THROUGH, THE NATURAL 1374 00:50:36,565 --> 00:50:39,869 MENOPAUSE IN MANY WAYS AS THE 1375 00:50:39,869 --> 00:50:41,103 QUESTIONER ASKS OR SUGGIESTED 1376 00:50:41,103 --> 00:50:44,507 IT'S MUCH MORE RAPID, WITH THE 1377 00:50:44,507 --> 00:50:49,111 OVARIES REMOVED YOU ALSO LOSE A 1378 00:50:49,111 --> 00:50:50,846 PORTION OF TESTOSTERONE 1379 00:50:50,846 --> 00:50:52,815 PRODUCTION THAT IS PRESENT BY 1380 00:50:52,815 --> 00:50:55,584 THE OVAFYS, IT'S A LOT OF 1381 00:50:55,584 --> 00:50:56,652 DENOAFY TESTOSTERONE OR 1382 00:50:56,652 --> 00:50:59,622 CONVERSION OF HORMONES LIKE 1383 00:50:59,622 --> 00:51:00,723 ADRENAL ANDROGENS INTO 1384 00:51:00,723 --> 00:51:01,056 TESTOSTERONE. 1385 00:51:01,056 --> 00:51:07,696 SO THAT IS AN ARK DITIONAL 1386 00:51:07,696 --> 00:51:08,831 ELEMENT. 1387 00:51:08,831 --> 00:51:09,965 THE EPIDEMIOLOGY, AND AND THERE 1388 00:51:09,965 --> 00:51:13,836 HAS BEEN BOTH STUDIES SUGGESTING 1389 00:51:13,836 --> 00:51:15,004 THERE CAN BE SIMILAR NATIVE 1390 00:51:15,004 --> 00:51:19,875 EFFECTS ON MOOD AND COGNITION 1391 00:51:19,875 --> 00:51:20,676 BUT THERE ALSO HAS BEEN SOME 1392 00:51:20,676 --> 00:51:21,911 CENTER FOR EXCELLENCE ON AGINGS 1393 00:51:21,911 --> 00:51:25,948 WHETHER IT'S A SURGICAL 1394 00:51:25,948 --> 00:51:26,315 [INDISCERNIBLE]. 1395 00:51:26,315 --> 00:51:27,149 AND MORE RECENT PAPERS IN 1396 00:51:27,149 --> 00:51:32,922 SCIENCE OR THE LAST COUPLE OF 1397 00:51:32,922 --> 00:51:34,957 YEARS SUGGESTING OVARIAN 1398 00:51:34,957 --> 00:51:35,991 SUPPRESS OR GONE ADAL 1399 00:51:35,991 --> 00:51:37,960 SUPPRESSION MAY HAVE BENEFICIAL 1400 00:51:37,960 --> 00:51:38,627 EFFECTS ON COGNITIVE FUNCTION 1401 00:51:38,627 --> 00:51:42,765 DOWN THE ROAD SO THE GAIP IS 1402 00:51:42,765 --> 00:51:46,402 SOMETHING THAT THERE'S A MIXED 1403 00:51:46,402 --> 00:51:54,743 COHORT IN TERMS OF FOR A THEY 1404 00:51:54,743 --> 00:51:56,712 MAY CONTRIBUTE TO MOOD OR 1405 00:51:56,712 --> 00:51:59,214 COGNITIVE CHANGES SO IT'S LESS 1406 00:51:59,214 --> 00:52:05,087 CLEAR I THINK THAN KIND OF SOME 1407 00:52:05,087 --> 00:52:05,821 OF THESE STUDIES. 1408 00:52:05,821 --> 00:52:07,957 >> NEXT JUST A COMMENT, THANK 1409 00:52:07,957 --> 00:52:11,260 YOU DR. SCHMIDT FOR SUCH A 1410 00:52:11,260 --> 00:52:11,827 THOUGHT-PROVOKING HELPFUL 1411 00:52:11,827 --> 00:52:13,228 INFORMATION, I LOOK FORWARD 1412 00:52:13,228 --> 00:52:15,431 ABOUT READING MORE FOR THIS 1413 00:52:15,431 --> 00:52:15,931 CLINICAL RESEARCH AREA. 1414 00:52:15,931 --> 00:52:25,774 >> THANK YOU VERY MUCH. 1415 00:52:25,774 --> 00:52:26,041 >> YEAH. 1416 00:52:26,041 --> 00:52:30,112 >> JUST 1 COMMENT SO ROANA LAB 1417 00:52:30,112 --> 00:52:32,748 HERE AT THE NIH HAS A VERY 1418 00:52:32,748 --> 00:52:34,917 INTERESTING STORY THAT SOMEBODY 1419 00:52:34,917 --> 00:52:37,886 SHE WILL SHARE RELATED TO ER 1420 00:52:37,886 --> 00:52:39,388 BETA AND AGE RELATED HEARING 1421 00:52:39,388 --> 00:52:43,492 LOSS IN WOMEN, SO THAT'S 1422 00:52:43,492 --> 00:52:44,526 SOMETHING THAT THEY'RE VERY 1423 00:52:44,526 --> 00:52:45,694 INVESTED IN AND WE'RE WORKING 1424 00:52:45,694 --> 00:52:47,696 WITH THEM TO TRY TO SEE IF WE 1425 00:52:47,696 --> 00:52:49,098 CAN FIND SOME OF OUR COMPOUND TO 1426 00:52:49,098 --> 00:52:53,902 LOOK AT IN THAT GROUP. 1427 00:52:53,902 --> 00:52:55,404 >> I WAS GOING TO ASK A QUESTION 1428 00:52:55,404 --> 00:52:58,374 ABOUT KEEPING THESE WOMEN IN THE 1429 00:52:58,374 --> 00:52:59,108 TRIAL DESPITE APPARENT 1430 00:52:59,108 --> 00:53:00,376 DEPRESSION AND HOW MUCH WORK IT 1431 00:53:00,376 --> 00:53:02,144 IS TO FOLLOW PATIENTS 1432 00:53:02,144 --> 00:53:04,446 LONGITUDINALLY IN THESE TYPES OF 1433 00:53:04,446 --> 00:53:06,682 TRIALS? 1434 00:53:06,682 --> 00:53:11,520 >> YES, YES, WELL IT'S YOU CAN 1435 00:53:11,520 --> 00:53:14,323 ASK XIOMING ABOUT IT, IT'S WORSE 1436 00:53:14,323 --> 00:53:15,758 FROM THE PEDIATRIC END 1437 00:53:15,758 --> 00:53:17,559 APPARENTLY, I TRY TO STAY AWAY 1438 00:53:17,559 --> 00:53:19,662 FROM THAT GROUP, I LIKE TO HEAR 1439 00:53:19,662 --> 00:53:22,331 REPORTS WHEN STAFF ARE 1440 00:53:22,331 --> 00:53:24,033 MISBEHAVING THAT'S MY MAIN ROLE 1441 00:53:24,033 --> 00:53:26,602 BUT OTHERWISE IT'S HANDS-OFF. 1442 00:53:26,602 --> 00:53:28,404 BUT IN PERIMENOPAUSE, THE WOMEN 1443 00:53:28,404 --> 00:53:29,371 WHO DEVELOPED DEPRESSION, IT'S 1444 00:53:29,371 --> 00:53:30,539 OCCURRING IN A CONTEXT OF A 1445 00:53:30,539 --> 00:53:33,575 RELATIONSHIP, SO IN CONTRAST TO 1446 00:53:33,575 --> 00:53:36,345 WHAT MANY PEOPLE THINK ABOUT THE 1447 00:53:36,345 --> 00:53:38,347 RESEARCH, WE'RE--YOU KNOW 1448 00:53:38,347 --> 00:53:39,314 FOLLOWING THEM VERY CLOSE AND WE 1449 00:53:39,314 --> 00:53:41,517 TAKE THE TIME TO DEVELOP THESE 1450 00:53:41,517 --> 00:53:45,888 RELATIONSHIPS AND THEIR VERY 1451 00:53:45,888 --> 00:53:49,191 CONNECTED TO THE STAFF, ALL 5 OR 1452 00:53:49,191 --> 00:53:50,726 6 THAT ARE HERE SO THEY'LL TALK 1453 00:53:50,726 --> 00:53:52,795 TO US AND I THINK WE'LL WORK 1454 00:53:52,795 --> 00:53:54,763 WITH THEM AS TO WHETHER THIS IS 1455 00:53:54,763 --> 00:53:55,564 SOMETHING THAT THEY FEEL THEY 1456 00:53:55,564 --> 00:53:57,566 WOULD LIKE TO COPE WITH, MANY OF 1457 00:53:57,566 --> 00:54:01,737 THESE DEPRESSIONS WERE 1458 00:54:01,737 --> 00:54:03,138 IDENTIFIED EARLY ON AND WERE 1459 00:54:03,138 --> 00:54:05,407 MORE MINOR WHICH WE KNOW CAN 1460 00:54:05,407 --> 00:54:06,809 DEVELOP INTO MORE MAJOR 1461 00:54:06,809 --> 00:54:07,776 DEPRESSIONS, YOU KNOW THE POINT 1462 00:54:07,776 --> 00:54:09,178 WOULD BE THERE WOULD BE A LINE 1463 00:54:09,178 --> 00:54:10,345 WHERE THEY WOULD NOT FEEL 1464 00:54:10,345 --> 00:54:11,747 COMFORTABLE AND THEY WOULD BE 1465 00:54:11,747 --> 00:54:14,183 WANTING TREATMENT AND THEY WOULD 1466 00:54:14,183 --> 00:54:15,050 STOP THE STUDY. 1467 00:54:15,050 --> 00:54:16,685 AND WE WOULD JUST FOLLOW THEM 1468 00:54:16,685 --> 00:54:18,954 MAYBE TO FIND OUT WHEN THEIR 1469 00:54:18,954 --> 00:54:19,888 LAST MENSTRUAL PERIOD WAS AND 1470 00:54:19,888 --> 00:54:22,891 THERE'S A NUMBER OF THOSE WOMEN 1471 00:54:22,891 --> 00:54:23,792 THAT WERE THERE. 1472 00:54:23,792 --> 00:54:25,227 OTHERS, YOU KNOW, WE WERE 1473 00:54:25,227 --> 00:54:26,729 WILLING TO GO WITH WHAT THEY 1474 00:54:26,729 --> 00:54:28,931 WANTED TO DO AND THEY FELT THAT 1475 00:54:28,931 --> 00:54:32,000 THEY WERE COPING FINE. THIS AN 1476 00:54:32,000 --> 00:54:32,935 OUTPATIENT DEPRESSION AND THEY 1477 00:54:32,935 --> 00:54:35,437 WANTED TO SEE WHETHER IT WOULD 1478 00:54:35,437 --> 00:54:36,972 REMIT ON ITS OWN AND THEY WOULD 1479 00:54:36,972 --> 00:54:42,044 CARRY ON AND SOME OF THEM DID, 1480 00:54:42,044 --> 00:54:42,644 OTHERS DIDN'T. 1481 00:54:42,644 --> 00:54:44,213 AND THERE'S A LOT OF MEDICAL 1482 00:54:44,213 --> 00:54:45,147 ILLNESS THAT HAPPENS AT THIS 1483 00:54:45,147 --> 00:54:46,682 TIME AND THOSE WOMEN WERE 1484 00:54:46,682 --> 00:54:47,983 EXCLUDED FROM THE DATA ANALYSIS, 1485 00:54:47,983 --> 00:54:52,187 BUT YOU KNOW A LOT OF MEDICAL 1486 00:54:52,187 --> 00:54:54,890 THINGS HAPPEN YOU KNOW KIND OF 1487 00:54:54,890 --> 00:54:58,193 TRIBUTE TO DEPRESSION BUT THAT 1488 00:54:58,193 --> 00:54:59,128 WE COULDN'T SOLELY ACKNOWLEDGE 1489 00:54:59,128 --> 00:55:03,699 ITS LINK TO THE PERIMENOPAUSE. 1490 00:55:03,699 --> 00:55:05,667 BUT IN THE CLINIC WHEN WE SEE 1491 00:55:05,667 --> 00:55:07,035 THEM THIS OFTEN, THAT'S WHERE 1492 00:55:07,035 --> 00:55:09,838 EACH OF THEM IS LIKE A CASE 1493 00:55:09,838 --> 00:55:12,241 REPORT, PROGRESS NOTES AND WE 1494 00:55:12,241 --> 00:55:13,976 CAN LOOK BACK ON THAT AND SEE 1495 00:55:13,976 --> 00:55:17,045 WHAT WAS HAPPENING WITH EACH 1496 00:55:17,045 --> 00:55:17,813 INDIVIDUAL WOMAN. 1497 00:55:17,813 --> 00:55:19,348 AND THAT'S THE IMPORTANCE OF THE 1498 00:55:19,348 --> 00:55:20,916 ABILITY OF THESE LONGITUDINAL 1499 00:55:20,916 --> 00:55:23,786 STUDIES AT NIH BECAUSE IN AN 1500 00:55:23,786 --> 00:55:25,420 EPIDEMIOLOGIC STUDY, YOU KNOW, 1501 00:55:25,420 --> 00:55:26,822 THERE'S THE HUGE DATA COLLECTION 1502 00:55:26,822 --> 00:55:28,624 EFFORT THAT STANDS BETWEEN YOU 1503 00:55:28,624 --> 00:55:31,293 AND THE PATIENT AND SO THERE'S 1504 00:55:31,293 --> 00:55:33,462 CERTAIN NUANCE EVENTS OF THEIR 1505 00:55:33,462 --> 00:55:34,429 EXPERIENCE THAT DON'T GET 1506 00:55:34,429 --> 00:55:35,230 CAPTURED AND THE RELATIONSHIP IS 1507 00:55:35,230 --> 00:55:38,033 NOT THERE SO YOU MAY NOT 1508 00:55:38,033 --> 00:55:39,001 ACTUALLY HAVE CHANNELS OPEN TO 1509 00:55:39,001 --> 00:55:46,975 HEAR ABOUT SOME OF THESE THINGS. 1510 00:55:46,975 --> 00:55:50,913 SO ... 1511 00:55:50,913 --> 00:55:52,114 >> SO DR. SCHMIDT, MIGHT A WOMAN 1512 00:55:52,114 --> 00:55:54,750 WHO HAS A HISTORY OF DEPRESSION 1513 00:55:54,750 --> 00:55:57,686 REQUEST HER GYNECOLOGIST OR PC P 1514 00:55:57,686 --> 00:56:01,390 REQUEST THEY MEASURE HER FSH IN 1515 00:56:01,390 --> 00:56:02,658 HER PERIMENOPAUSAL PERIOD IN. 1516 00:56:02,658 --> 00:56:04,693 >> YEAH, I THINK THE CRITERIA, 1517 00:56:04,693 --> 00:56:08,330 THE STAGES OF REPROUCT DIDDIVE 1518 00:56:08,330 --> 00:56:10,399 ANALLING WORKSHOP, THEY RELY 1519 00:56:10,399 --> 00:56:12,267 LESS ON FSH AND INHIB THORSIN 1520 00:56:12,267 --> 00:56:13,569 ISSUE THE ASSAY IS GETTING 1521 00:56:13,569 --> 00:56:15,304 BETTER, I'M NOT SURE IT'S READY 1522 00:56:15,304 --> 00:56:17,739 FOR PRIME TIME BUT I THINK THE 1523 00:56:17,739 --> 00:56:19,007 MOST IMPORTANT CRITERIA WOULD BE 1524 00:56:19,007 --> 00:56:21,877 IF THEY ARE SKIPPING CYCLES OR 1525 00:56:21,877 --> 00:56:23,512 IF THEIR CYCLES HAVE CHANGED IN 1526 00:56:23,512 --> 00:56:23,846 LENGTH. 1527 00:56:23,846 --> 00:56:28,617 THEY TALK ABOUT A WEEK SHORTER 1528 00:56:28,617 --> 00:56:30,419 OR A WEEK LONGER, IF THERE'S A 1529 00:56:30,419 --> 00:56:33,789 CHANGE IN THE BLOODING PATTERN, 1530 00:56:33,789 --> 00:56:34,890 OFTEN PLEADING BECOME HEAVIER 1531 00:56:34,890 --> 00:56:38,093 DURING THIS TIME, PLUS OR MINUS 1532 00:56:38,093 --> 00:56:40,028 OTHERRICISM TOPS OF 1533 00:56:40,028 --> 00:56:41,496 INSUFFICIENCY, WHETHER IT'S 1534 00:56:41,496 --> 00:56:43,498 VAGINAL DRYNESS OR HOT FLASHES, 1535 00:56:43,498 --> 00:56:45,133 THEY NOT NEED TO CONFIRM THAT 1536 00:56:45,133 --> 00:56:46,335 BUT CERTAINLY HAD MANY WOMEN IN 1537 00:56:46,335 --> 00:56:49,504 THE CLIPPIC THEY HAVE HAD 1538 00:56:49,504 --> 00:56:52,174 MEASURES OF FSH, ESTRO DIAL, THE 1539 00:56:52,174 --> 00:56:53,242 ASSAYS FOR ESTRA-DIAL WHEN IT 1540 00:56:53,242 --> 00:56:54,743 GERONTOLOGYSTSS LOW ARE NOT VERY 1541 00:56:54,743 --> 00:56:56,044 RELIABLE UNLESS YOUR USING 1542 00:56:56,044 --> 00:56:58,213 THINGS LIKE MASS SPEC, SO MANY 1543 00:56:58,213 --> 00:56:59,181 GYNECOLOGISTS WILL DO THAT BUT 1544 00:56:59,181 --> 00:57:00,716 MANY OF THEM ALSO WILL FEEL 1545 00:57:00,716 --> 00:57:01,984 COMFORTABLE JUST BY THE WOMAN'S 1546 00:57:01,984 --> 00:57:04,052 AGE AND SOME OF THE OTHER 1547 00:57:04,052 --> 00:57:05,787 SYMPTOMS OF THEIR MENSTRUAL 1548 00:57:05,787 --> 00:57:08,924 CYCLE HISTORY THIS THEY DON'T 1549 00:57:08,924 --> 00:57:10,392 REQUIRE. 1550 00:57:10,392 --> 00:57:11,727 HORMONE MEASURES. 1551 00:57:11,727 --> 00:57:13,362 >> WE MAYBE HAVE TIME FOR 1 LAST 1552 00:57:13,362 --> 00:57:13,629 QUESTION. 1553 00:57:13,629 --> 00:57:14,763 THIS WILL BE SHORT. 1554 00:57:14,763 --> 00:57:17,599 HAD MANY OF THE PATIENTS IN YOUR 1555 00:57:17,599 --> 00:57:19,234 STUDY SUFFERED FROM PTSD? 1556 00:57:19,234 --> 00:57:22,371 >> WELL IT'S SOMETHING THAT 1557 00:57:22,371 --> 00:57:23,205 CONSTANCE IS LOOKING AT. 1558 00:57:23,205 --> 00:57:26,842 I THINK WE ARE LOOKING AT EARLY 1559 00:57:26,842 --> 00:57:27,743 LIFE TRAUMA. 1560 00:57:27,743 --> 00:57:33,248 SO I THINK THAT IS WHAT WE FELT 1561 00:57:33,248 --> 00:57:34,483 WAS IMPORTANT. 1562 00:57:34,483 --> 00:57:37,719 NONE OF THE MET CRITERIA ON THE 1563 00:57:37,719 --> 00:57:39,154 STRUCTURED DIAGNOSTIC INTERVIEW 1564 00:57:39,154 --> 00:57:41,623 FOR PTSD KIND OF BEFORE HAND, AT 1565 00:57:41,623 --> 00:57:43,158 LEAST NOT MANY OF THEM, BUT MANY 1566 00:57:43,158 --> 00:57:46,962 OF THEM DO HAVE AND THERE IS A 1567 00:57:46,962 --> 00:57:49,564 LITERATURE RELATED TO EARLY LIFE 1568 00:57:49,564 --> 00:57:53,969 STRESS WHICH IS A COMPLICATED 1569 00:57:53,969 --> 00:57:56,071 RELATIONSHIP WITH REPORTS OF 1570 00:57:56,071 --> 00:57:58,740 PTSD, BOTH IN TERMS OF 1571 00:57:58,740 --> 00:57:59,174 FALSE-NEGATIVES AND 1572 00:57:59,174 --> 00:58:00,542 FALSE-POSITIVES BUT WE HAVE THAT 1573 00:58:00,542 --> 00:58:03,578 INFORMATION AND WE WILL BE 1574 00:58:03,578 --> 00:58:04,346 LOOKING AT THAT. 1575 00:58:04,346 --> 00:58:06,715 BUT CERTAINLY IN WOMEN IN 1576 00:58:06,715 --> 00:58:08,951 GENERAL WHO PRESENT TO 1577 00:58:08,951 --> 00:58:09,985 BEHAVIORIAL HEALTH CLINICS, 1578 00:58:09,985 --> 00:58:12,054 THERE'S ABOUT A 60% OR HIGHER 1579 00:58:12,054 --> 00:58:16,391 RATE OF EARLY LIFE TRAUMA, SO, I 1580 00:58:16,391 --> 00:58:19,962 THINK THAT'S WHY PTSD IS NOT AN 1581 00:58:19,962 --> 00:58:21,697 UNCOMMON ANTISEEDENT TO A LOT OF 1582 00:58:21,697 --> 00:58:23,932 THESE CONDITIONS. 1583 00:58:23,932 --> 00:58:24,800 THANK YOU. 1584 00:58:24,800 --> 00:58:29,905 I THINK THAT REALLY IS IT. 1585 00:58:29,905 --> 00:58:40,182 THANK YOU.